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Stellingen
behorende bij het proefschrift:
13In vivo C MR spectroscopy for human investigations
1. De associatie van het getal 13 met ongeluk is niet altijd terecht, het voorkomen van 
een koolstofvariant met 13 kerndeeltjes is voor de MR spectroscopist een geluk te 
noemen (dit proefschrift).
2. De toepassing van protonontkoppeling ten behoeve van humaan onderzoek kan 
geschieden binnen de geldende limieten voor RF depositie (dit proefschrift).
3. Op basis van temperatuur en vermogens metingen gedurende proton ontkoppeling 
kan geconcludeerd worden dat de richtlijnen voor specifieke absorptie ratio te con­
servatief zijn (dit proefschrift).
4. Signaalruisverbetering door middel van heteronucleaire polarizatie transfer geeft in 
vivo 13C MR spectroscopie een meer dynamisch karakter (dit proefschrift).
5. Glucosevoeding resulteert in een sneller spierglycogeenherstel dan fructosevoeding 
(dit proefschrift).
6 . De spierglycogeenvorming en de totale spier glucoseconcentratie tijdens een hy- 
perinsulinemische euglycemische clamp zijn beide goede parameters voor insuline 
sensitiviteit (dit proefschrift).
7. Afrikaanse percussie wordt het best benaderd door de kakofonie van de gradiënten 
tijdens een map shim sequentie (eigen waarneming).
8. Het illegale CDcircuit zorgt niet alleen voor inkomstenderving van vele artiesten maar 
ook voor een grotere naamsbekendheid.
9. Bij het beklimmen van een steile heuvel met de ATB speelt niet zozeer gewicht een 
rol maar eerder de verdeling daarvan (eigen waarneming).
10. Door het plaatsen van meerdere spectroscopisten in één werkkamer neemt niet
alleen de ruis toe, maar ook het signaal af (anonieme kamergenoot).
Nijmegen, 13 april 1999
A.J. van den Bergh
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History of MR
The phenomenon of nuclear magnetic resonance (NMR) was demonstrated for 
the first time in 1946 independently by Bloch et al. and Purcell et al. ; in 1952 they 
received the Nobel prize for their discovery (1, 2). The chemical shift, the 
property of a small but specific displacement of the resonance frequency of a 
particular nucleus in a different chemical compound made NMR to one of the 
most powerful analytical tools in chemistry and biochemistry. Since the 1950’s 
NMR is used as a tool for studying chemical structure, configuration, and 
chemical reaction processes.
In 1973, it was Lauterbur, who gave the first demonstration of the concept of 
magnetic resonance imaging (3). Pictures of fruit, animals and finally humans 
were obtained later during the 70’s. In the same period Hoult et al. reported in 
1974 on the application of NMR spectroscopy to intact, freshly excised muscle 
from the leg of a rat (4). More studies followed on the isolated heart, liver and 
other organs. Subsequently, the logical step from these tissue studies to in vivo 
NMR spectroscopy of whole animals was made (5).
Since the first commercial MR scanners for human examinations became 
available around 1981, both magnetic resonance imaging (MRI), and in vivo 
magnetic resonance spectroscopy (MRS) rapidly evolved. MRI has become a 
major imaging modality in radiology. Besides the use of MRI as a tool to study 
the internal anatomy of the body, it has also been used to obtain functional
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information; i.e. of brain activity, several recent review articles have summarized 
the current status on this topic (6-9).
With MRS one can have access to physiology and biochemistry of living human 
tissue. The biochemical status of the human body can be assessed in a non­
invasive manner, which makes it possible to perform longitudinal examinations to 
study the dynamics of biochemical processes in the human body.
Basics of MR
A nucleus is composed of protons and neutrons. These nucleons have spins, 
and the spin of a nucleus as a whole is the vector sum of the spins of the 
individual nucleons. This vector sum varies from one nucleus to another, and 
depends on the way nucleons are coupled to each other. If this vector sum is not 
equal to zero, than the nucleus has a magnetic moment. A nucleus that possess 
a magnetic moment can be used to perform an NMR experiment. The hydrogen 
atom H, with one proton in its nucleus is one of the most important nuclei in 
biological MR.
Without the presence of an external magnetic field the spins of these nuclei are 
randomly oriented, so there will be no net magnetization. In the presence of a 
magnetic field, the nuclei will align parallel or anti-parallel along the applied field 
axis. The parallel orientation has a slightly lower energy state, therefore more 
nuclei will align parallel and produce a net magnetic moment (macroscopic 
magnetization).
This magnetic moment is not exactly aligned with the external magnetic field but 
it precesses around it. The frequency with which it precesses is given by the 
Larmor equation.
V0 = yB0/2n [1]
In which g is the gyromagnetic ratio (dependent on the type of nucleus), B0 is the 
strength of the applied external magnetic field, and v 0 is the frequency of 
precession (Larmor frequency). Both g and B0 determine the energy difference
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between the parallel and anti parallel states. A higher energy difference (higher 
product of gB0) leads to a larger population difference between the states, and 
thus to a proportionally higher sensitivity. This is one of the reasons why MR 
spectroscopists keep buying more powerful magnets. Another advantage is the 
improved spectral resolution at higher field strengths. This can be explained by 
looking at equation 2.
V = g(B0 -oB0)/2rc [2]
The screening factor s  is introduced, it depends on the chemical environment of 
each nucleus. From the equation it is clear that the frequency v is proportional 
the external magnetic field B0. The effect of g on the frequency is large compared 
to the effect of s. So resonance frequencies differ strongly going from one 
nuclear species to another, and slight differences occur within one nuclear 
species, these differences in frequency depending on the chemical environment 
are called chemical shift.
In order to create an MR image or spectrum, the resonance condition must be 
fulfilled. There must be a situation of alternating absorption and dissipation of 
energy. By applying a radio frequency (RF) magnetic field at the Larmor 
frequency “on resonance”, the nuclei can be placed in a higher energy state by 
the absorption of the RF energy. When returning back to the low energy state, 
the spins emit RF energy to the environment, which can be picked up by a 
receiver coil. The application of different RF pulses and RF acquisition schemes 
in combination with the use of magnetic field gradients can result in MR images 
or spectra.
Isotopes of interest for clinical in vivo MR spectroscopy
The atomic nuclei that are potentially useful for biomedical in vivo MR 
spectroscopy applications are given in table 1. with their MR related properties. 
Brief descriptions of the most commonly applied nuclei for in vivo MR 
spectroscopy studies are given below.
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1
H: this nucleus has almost 100% natural abundance and is present in most 
biochemicals. It has the highest intrinsic sensitivity of all stable nuclei, and 
it is therefore a very interesting nucleus for in vivo MR spectroscopy. 
Some important metabolites detectable by H MR spectroscopy are: 
choline compounds, citrate, creatine, glutamate, glutamine, lactate, myo­
inositol and N-acetyl-aspartate. It has two drawbacks, the limited chemical 
shift range and the need for water and lipid signal suppression. Its main 
applications are in brain, muscle and prostate spectroscopy. (10-13)
31 P: phosphorus has a 100% natural abundance and a reasonable sensitivity. It 
is very suitable for the study of high energy phosphate metabolites and 
other phosphorus containing metabolites such as phospho mono- and di-
31esters. Applications of in vivo P MR spectroscopy are in the study of 
muscle, cardiac, and brain metabolism and also in monitoring tumor
31therapy (14-24). Besides the study of metabolites, P MR spectroscopy 
can be used as a noninvasive technique to monitor the intracellular pH 
(25-27).
13 13 12C: C has only 1.1% natural abundance ( C has an occurrence of over 98% 
and no magnetic moment) and a low intrinsic sensitivity. It can be detected 
in a large number of biochemically important compounds in a broad 
spectral range. Furthermore, the ability to use selectively enriched 
substrates for the study of metabolic pathways makes this nucleus 
interesting for in vivo applications.
19 19F: the abundance of the F nucleus is 100% and its sensitivity almost equals 
that of protons. Because of its presence in tumor therapeutics, this 
nucleus has a particular clinical interest (28-33).
13In spite of the low sensitivity of C, this nucleus is very well suited for obtaining
biochemically important information. This thesis is focused on the application of
13in vivo C MR spectroscopy in human investigations. In the next sections, the
13current status of human in vivo C MR spectroscopy is reviewed.
12
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Nucleus Spin g/2p
(MHz/Tesla)
Natural Abundance 
(%)
1
Sensitivity vs. H
1H 1/2 42.57 99.98 1
13C 1/2 10.71 1.108 0.00025
14n 1 3.08 99.63 0.0019
15n 1/2 -4.31 0.37 0.0000068
17O 5/2 -5.77 0.037 0.000019
19f 1/2 40.05 100 0.85
23Na 3/2 11.26 100 0.13
31 p
1/2 17.24 100 0.83
39k 3/2 1.99 93.1 0.001
Table 1.
Spin, gyromagnetic ratios, natural abundance and relative sensitivity compared to proton, of 
biological interesting nuclei.
13Human metabolism studied by in vivo C MR spectroscopy 
Natural abundance:
13Natural abundance C MR spectroscopy is limited to highly concentrated 
compounds such as triglycerides and glucose units in glycogen, because of the 
low intrinsic sensitivity of this technique.
The resonances of triglycerides are dispersed over a broad spectral range.
1 13Signals that co-resonate in the H spectrum can be resolved in the C spectrum,
13which makes C the favorable technique for the study of triglycerides, despite its 
lower sensitivity. Special interest goes to the degree of saturation of lipids (34). It 
has been shown that in neonatal development the amount of unsaturated fatty 
acids increase with maturity (35). In this study similar differences were found for
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gestational age. Preterm infants showed a relatively lower unsaturated fatty acid 
content compared to full term infants. The relation between diet and adipose 
tissue fatty acid composition was also studied. The ratio of unsaturated to total 
fatty acid composition in adipose tissue correlated with the same ratio as in diet 
fat, after a minimal diet period lasting half a year (36). Another study revealed 
differences in the adipose tissue composition of vegans compared to vegetarians 
and omnivores (37). Vegans showed a higher level of unsaturated fatty acids. 
Differences in the degree of saturation of fatty acids were reported of carcinoma 
compared to non-cancerous tissue of human breast (38). The comparison of
13cystic fibrosis patients with healthy volunteers by in vivo C MR spectroscopy 
revealed a difference in the amount of polyunsaturated fatty acid content (39).
13More challenging in natural abundance in vivo C MR spectroscopy is the 
detection of metabolites such as glycogen, creatine, citrate, myo-inositol. Jue et 
al. demonstrated that the C-1 signal of glycogen is observable in humans, the
13other glycogen signals are less well resolved (40). C MR spectroscopy has 
emerged as an appropriate noninvasive alternative for biopsy methods for the 
detection of muscle glycogen (41). Several studies report on muscle glycogen 
depletion and repletion after exercise (42-48). Price et al. investigated the 
glycogen resynthesis after depletion and found an insulin dependent and insulin 
independent phase after depletion up to 25% (45). Other studies focused on the 
glycogen resynthesis with carbohydrate intake during the recovery period (46­
48). Glucose feeding during recovery resulted in a faster resynthesis rate 
compared to fructose ingestion (47).
Natural abundance detection of glycogen is also possible in vivo in the human 
liver (42, 49-53).
A more clinical application of the study of glycogen metabolism is in glycogen 
storage disease, in which muscular or liver glycogen content can be studied non-
13invasively by natural abundance C MR spectroscopy (54-57).
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Other potentially clinical important metabolites that can be detected by in vivo
13natural abundance C MR spectroscopy are citrate (58), myo-inositol (59-61) 
and creatine (42, 47, 62).
13C labeling:
13One can benefit from the low natural abundance of the C nucleus in the human
13body and that is by the application of selectively C enriched substrates. After
13the administration of C labeled substrates the observation of the applied label 
and its metabolic intermediates or end products can be used to study fluxes 
through metabolic pathways. These techniques can be applied to study brain, 
liver and muscle metabolism.
Beckmann et al. demonstrated in 1991 that labeled C-1 glucose and its labeled 
metabolic products C-2, C-4 and C-3 glutamate/glutamine and lactate could be 
detected in the human brain in vivo during hyperglycemic glucose clamping (63).
1 13In the same year, it was shown by H detected C MR spectroscopy that glucose 
was actively metabolized to lactate in a patient with a 32 day old cortical infarct 
(64). Glucose steady state concentrations and glucose transport activity into the
13brain were also determined with the use of labeled C-1-glucose in combination 
with in vivo brain MR spectroscopy (65, 66). Other in vivo brain MR spectroscopy 
studies demonstrated that this technique can provide more information than 
positron emission tomography (PET) regarding the metabolic processes beyond 
the uptake of glucose into the brain, the metabolic flux from glucose to glutamate 
could be followed (67, 68). Using a mathematical model, several metabolic rates
13for the human neocortex could be determined from in vivo C MR spectroscopy 
data (69). Shulman et al. discussed the role of MR spectroscopy and other MR 
techniques in the study of brain function (70).
The incorporation of labeled C-1-glucose has also been studied in the liver (71, 
72). It was demonstrated that liver glycogen synthesis and breakdown occur 
simultaneously during net glycogen synthesis (73). Studies comparing healthy 
subjects with patients with poorly controlled insulin dependent diabetes mellitus
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(NIDDM) demonstrate that these patients have an increased hepatic 
gluconeogenesis and relative decreased rates of hepatic pyruvate oxidation (74).
13The fate of infused labeled C-1-glucose in muscle tissue is important in the 
study of exercise and diabetes. In 1989, Jue et al. showed that under conditions 
of hyperglycemia and hyperinsulinemia, a majority of the infused glucose was 
converted to muscle glycogen in normal man (76). Using the same method it was 
shown that defects in muscle glycogen synthesis have a dominant role in the 
insulin resistance that occurs in patients with NIDDM (77). It was demonstrated 
that the degradation and synthesis of muscle glycogen can occur simultaneously
13 31during prolonged low-intensity exercise (75). Combined C / P MR 
spectroscopy suggests that the post-transport steps do not play a significant role 
in the control of muscle glucose disposal, and that glucose transport/hexokinase 
activity maybe impaired in patients with NIDDM (78-81). Similar conclusions were 
drawn for insulin resistant obese subjects (82).
13All of the human in vivo C MR spectroscopy studies mentioned above used 
labeled glucose as a substrate for infusion. There is a great potential in the use 
of other labeled compounds as currently in use in in vivo animal studies or 
isolated organ studies. For example to study the pharmacology of certain types 
of drugs (83-86). Also the use of multi-labeled compounds can be of clinical 
interest because of the additional information that can be obtained due to the
13spin spin interaction of adjacent C nuclei (87-90).
13In vivo C MR spectroscopy: double resonance
13Most of the metabolites studied by in vivo C MR spectroscopy have attached
1 13protons. The spin spin interaction that exists between neighboring H and C
13nuclei results in a multiplet splitting in the C spectrum. The multiplet structure
13obtained in the C spectrum is dependent on the number of attached protons to
13the C nucleus. If the number of attached protons equals n, than the multiplet 
consists of n+1 peaks, thus information about the molecular structure can be
16
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obtained. However, these multiplets complicate spectrum analysis and decrease
13sensitivity. In order to utilize the full potential of in vivo C MR spectroscopy it is
1 13necessary to remove these H- C multiplet splittings by proton decoupling during
13 1the C signal acquisition period. The spectrum obtained with H decoupling is 
simplified and sensitivity is enhanced by gathering all the intensity of a multiplet 
into a singlet.
1 13H- C decoupling and other double resonance techniques require some special 
hardware which is not standard installed on a clinical imaging system, such as a 
second radio frequency channel, filters to ensure signal separation and a dual 
frequency high sensitivity coil (see below).
The application of a radio frequency decoupling field for in vivo studies in 
humans is of concern since it could lead to tissue heating (91). At the present 
time, two levels of concern are issued by the US Food and Drug Administration 
(FDA): guidelines for specific absorption rate (SAR) and temperature increase 
induced by RF (92).
Selective decoupling of a single proton frequency requires minimal energy, this 
method is often applied for the detection of the C-1 resonance of glycogen in 
liver and muscle (43, 49). This approach is very useful if one is interested in one 
particular metabolite signal, other signals present in the spectrum remain proton 
coupled.
Broadband proton decoupling results in higher SAR levels, but it may help to 
reveal additional metabolite signals and to uncover resonances otherwise 
obscured by the intense triglyceride signals. Studies performed at the clinical 
field strength of 1.5T indicate that broadband proton decoupling using WALTZ 
sequences is possible within FDA guidelines (42, 54). Broadband decoupling at 
higher field strength requires more power, not only because of the broader 
chemical shift range to be covered, but also due to the higher frequency (f), 
according to Röschmann [SAR] ^  f2145 (93). Bomsdorf et al. suggested that 
broadband proton decoupling at 4T would violate safety guidelines (51). 
Recently, Gruetter et al. demonstrated the possibility of broadband proton
17
Chapter 1
decoupling at 4T using a quadrature proton coil (94, 95). For these 
measurements at 4T the relationship between SAR and frequency holds true. 
However, recently this relationship has been refuted for ultra high magnetic field 
strengths on a whole body 8T system (96).
The RF field inhomogeneity of surface coils leads to an inefficient use of RF 
power required for decoupling (97, 98). B2 insensitive hyperbolic secant pulses 
used for decoupling can result in lower SAR values for broadband decoupling 
compared to WALTZ type sequences (99, 100).
Application of a decoupling RF field can also result in Nuclear Overhauser 
Enhancement (NOE), so sensitivity is further improved. The effect of NOE and 
decoupling were investigated for phantoms and lipid tissue of the human calf and 
breast (101). Bi-level irradiation for optimal NOE and decoupling as used in in
31 13vivo P MR spectroscopy are not often used in C MR spectroscopy because of 
the increased SAR level (102, 103).
Another means of signal enhancement by double resonance techniques is
1 13transfer of polarization. Polarization transfer from H to C can result in a signal
1 13enhancement of g H/g C » 4. The highest possible signal can be obtained when 
excitation and detection are performed on the sensitive proton nucleus, this is 
the so-called indirect detection, enhancements of (g1H/g13C)5/2 » 32 can be 
achieved theoretically. Only a limited number of studies report on indirect
13detection of C in humans in vivo. Knüttel et al. demonstrated that indirect 
detection of the unsaturated fatty acid carbon signals and glycogen is possible in 
vivo using Cyclpot-Vosing (104, 105). This volume selective technique is based 
on multiple-quantum filtering (MQF) and cyclic polarization transfer. Indirect 
detection was also applied in the study of labeled compounds in normal brain 
metabolism and in a patient with stroke (64, 67). A modified proton observe 
carbon edited (POCE) sequence was recently used for the natural abundance 
detection of brain N-acetyl aspartate (106). As for the use of labels, the 
development in techniques is ahead in animal studies. A very promising
13technique which has yet only been applied in vivo in cat brain to monitor C-1­
18
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glucose and its metabolites is the gradient-enhanced heteronuclear multiple 
quantum coherence (ge-HMQC) technique (107).
As shown by the studies mentioned above, indirect detection offers high 
sensitivity, but it also has some disadvantages, it requires a good water 
suppression and it has a lower resolution compared to detection at the carbon 
nucleus.
1 13Several methods are in use for the transfer of polarization from H to C for 
sensitivity enhancement. The sine-dependent polarization transfer (SINEPT) 
technique was applied to humans in vivo for the detection of glycogen and fatty 
acid resonances (108, 109). This sequence requires no 180° pulses and due to 
its sequential arrangement of RF pulses it can be implemented on a single­
channel MR system. Distortionless enhancement by polarization transfer (DEPT) 
has also been applied in vivo to humans (95, 110). First attempts of Insensitive 
Nucleus Enhancement by Polarization Transfer (INEPT) were shown by Kreis et 
al. (111). An alternative approach, not based on pulse interrupted free 
precession, but by which transfer of magnetization is achieved by heteronuclear 
isotropic mixing, has recently been reported to be feasible in animals and 
humans (112, 113). An adiabatic variant of this heteronuclear cross polarization 
has been proposed for in vivo applications (114).
13These recent developments and improvements in double resonance in vivo C 
MR spectroscopy will facilitate the applications of these techniques in the clinical 
situation. Due to these developments a debate started comparing 18FDG PET
13with C-glucose MR spectroscopy (115, 116). Both techniques have their 
advantages and disadvantages and it is the research question that should 
determine the technique of choice.
13Radio Frequency coils for in vivo C MR spectroscopy
Radio frequency coils are used for transmitting and/or receiving. A crucial
13problem for in vivo C MR spectroscopy applied to humans is the need for
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proton decoupling with limited RF deposition so that safety guidelines are not
13exceeded. To perform a C in vivo experiment, a coil configuration is required
13 1with the highest possible sensitivity for C, and an efficient H coil for 
decoupling, while interactions between coils must be minimized.
13Therefore, surface coils are often used for C because of their good filling factor 
which yields a good signal to noise ratio. In addition, these types of coils allow a 
crude form of localization because of their inhomogeneous B1 field. For the 
proton decoupler coil several arrangements are possible in combination with the
13carbon surface coil. A circular concentric coplanar configuration with a inner C 
coil and an outer H coil has been used in several studies (49, 54, 101, 117). A 
problem that arises with these type of coils is the strong interaction between the
13coils, the RF of the proton coil is partially blocked by the C inner coil which can 
result in excessive power requirements for decoupling.
To reduce coil interactions, an orthogonal arrangement can be used. Figure-8 
and butterfly shaped coils are reported to obtain orthogonality in coil
13configurations (42, 47, 109, 118). The rapidly decreasing B2 field along the C 
coil axis can result in high local SAR values which is of concern with human 
application (98).
Alternatively, double tuned coils can be used which lack the blockage of the 
proton RF (119). Another advantage of these type of coils is the matching of the 
RF fields which is important in polarization transfer techniques (112). A 
disadvantage of double tuned coils is that it is difficult to achieve optimal 
performance for both nuclei and sufficient channel separation.
A more recent development, is a quadrature proton coil combined with a circular
13C coil (94). This coil combines the two important properties of a high sensitivity
13for C and an efficient proton decoupling.
Volume coils provide a homogeneous RF field and are therefore interesting for 
polarization transfer experiments. A combination of a volume proton coil with a
13C surface coil was used for polarization transfer by SINEPT (108). A birdcage 
transmit coil in combination with a double tuned surface receiver coil was used in
20
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the VOSING technique (104). Heteronuclear cross polarization was performed
13with a combination of a birdcage proton coil and a half volume C coil (113). 
Spatial localization for 13C MRS
As mentioned above, surface coils provide excellent signal to noise ratios and a 
crude form of localization. However, the volume sampled by a surface coil is not 
well defined. Therefore, additional techniques are required to obtain spectra from 
a volume of interest (VOI), without contamination with signal from outside the 
selected VOI.
13In in vivo C MR spectroscopy the intense signals originating from superficial 
lipid tissue are often unwanted. Suppression of these signals from outside the 
VOI can be performed in several ways. A simple method is by the application of 
a rectangular pulse with a high flip angle 180°- 200° in the plane of the surface 
coil (54). An alternative for this method is the use of an adiabatic rapid half 
passage excitation preceded by a low flip angle rectangular pulse followed by a 
dephasing gradient (42, 47). Tailored pulses for the detection of wanted signals 
and suppression of unwanted can also be used (49).
In the above described techniques the VOI is not sharply delineated, only 
unwanted signals form the surface are suppressed. A well defined VOI can be 
obtained by the application of frequency selective RF pulses in combination with 
B0 gradients. ISIS (image selected in vivo spectroscopy) (120) is a suitable single
13voxel technique for C because T2 relaxation losses are limited, another 
advantage is that signals are not adversely affected by J modulation as in spin­
echo sequences. ISIS was successfully used to obtain a 3D localized spectrum
13of the human brain (59). Due to the large chemical shift range of the C nucleus 
a chemical shift displacement error occurs when the technique of frequency 
selective excitation in combination with a B0 gradient is applied for localization. In 
localization by chemical shift imaging (CSI), this chemical shift displacement 
error is much smaller (121). Another advantage of CSI is that multiple voxels are
21
Chapter 1
13obtained within a single measurement. The use of C 1D CSI was demonstrated 
in vivo in humans (122). The detection of myo-inositol in the human brain was
13performed by C 3D CSI, showing that low concentrated compounds can be 
detected in a well defined volume (61).
13Another way to circumvent the large chemical shift displacement error in C MR 
spectroscopy is by excitation of the H nucleus followed by polarization transfer
13 1to C. In this way, the precise localization on H, the signal gain by polarization
13transfer and the high spectral resolution of the C nucleus are combined. Using 
this approach, localized spectra of the human calf muscle could be obtained 
(110). Gruetter et al. used localization based on ISIS, followed by DEPT 
polarization transfer on the human brain, the acronym PRECISELY is proposed 
(PRoton Excited C-13 Image-SElected in vivo Localized spectroscopY) (95). 
Kreis et al. demonstrated that the combination of PRESS and INEPT was 
feasible (111). Indirect detection methods (see double resonance section) also 
allow for the precise localization via the H nucleus.
Quantification
13In in vivo C MR spectroscopy often relative changes of metabolite levels are 
monitored. However, in many cases absolute quantification of metabolite levels 
is desired. Absolute quantification can be performed by using an external 
reference solution of known concentration. Taylor et al. compared muscle 
glycogen concentrations obtained with MR using external referencing with biopsy 
results and demonstrated a high accuracy for the MR spectroscopy 
determination (41). Absolute quantification by comparing data with a phantom 
has been demonstrated to be feasible for brain myo-inositol (59), for muscle 
glucose (80) and liver glycogen (57).
Tissue concentration determination of metabolites can also be made by internal 
referencing, using a biochemical compound of known concentration. The 
advantage of this method is that the reference signal originates from the same
22
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volume. The compounds under study should be homogeneously distributed over 
the tissue and completely MR visible. Creatine was used as an internal reference 
to quantify muscle glycogen (47, 123)
Absolute quantification of metabolites is difficult in spectra obtained with 
polarization transfer techniques. Whether an internal or external reference is 
used, the efficiency of polarization transfer of the metabolite under study and of 
the reference must be known exactly, in vivo efficiency levels are difficult to 
obtain.
Research goals
13For clinical acceptance of in vivo C MR spectroscopy it is important that 
techniques for data collection and analysis become possible in the clinical
13environment. Nearly all the research in in vivo C MR spectroscopy on humans 
has been performed on experimental MR systems at high magnetic field 
strengths > 2T. However, the standard clinical MR system, available in most 
clinical research institutes operates at 1.5T. The work presented in the next 
chapters was performed on a modified clinical imaging system; equipped with a 
second RF transmit channel. The main purposes of the current work are: 1) to
13optimize the C MR spectroscopy technique for human applications while 
ensuring patient safety; 2) to explore the utilization of this technique in human 
physiology and pathology related to glycogenesis.
Outline of this thesis
chapter 2: A method was developed to optimize decoupling power settings for 
surface coils by which RF deposition in the body could be reduced. 
Information obtained by this method was also used to calculate the 
amount of energy deposited in the tissue at the position of the 
highest RF field.
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Chapter 3: The thermoregulatory response of the skin was investigated during 
exposure to RF radiation with a surface coil at several power levels. 
The skin temperature of the calf muscle was monitored in healthy 
male subjects.
Chapter 4: The potential of heteronuclear cross polarization was investigated.
Phantom studies were performed, and in vivo studies on the human 
leg and on a neonatal piglet brain. The latter study was performed in
13combination with the introduction of labeled C-1-glucose.
Chapter 5: Glycogen recovery rates were studied in healthy male subjects after 
depletion. A comparison was made between glucose and fructose 
feeding during the recovery period.
Chapter 6: Insulin stimulated glycogenesis in muscle was studied in subjects 
ranging from insulin sensitive to insulin resistant, by the combination
13 13of in vivo C MR spectroscopy and infusion of C labeled glucose. 
In addition, the effect of treatment with troglitazone on insulin 
resistance was investigated.
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2Abstract
1 13For patient safety in human H decoupled C-MRS, it is absolutely necessary to 
evaluate the specific RF absorption rate (SAR) of the tissue exposed to H 
frequency irradiation. With the use of surface coils, the local SAR at the body 
surface is of most concern due to the inherent RF field inhomogeneity. An 
empirical procedure to spatially calibrate the decoupler power level and to 
evaluate the local SAR at the body surface is described. For head, liver, muscle 
gastrocnemius and muscle vastus lateralis the SAR at the body surface was
1 13estimated for an H/ C double surface coil setup. Optimized duty cycle values
1 13obtained with this procedure show that broadband H decoupled C-MR 
spectroscopy is clinically feasible at 1.5 T for such a coil configuration within 
safety guidelines.
---------------------------------------------------------------- ;--------------------1-------------------------------------------This chapter is based on the publication: Calibration of the H decoupling field strength
and experimental evaluation of the specific RF absorption rate in 1H-decoupled human 
13C-mRs. A.J. van den Bergh, H.J. van den Boogert, A. Heerschap, Magn Reson Med,
39: 642-646 (1998).
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Introduction
The use of radio frequency (RF) fields in magnetic resonance applied to humans
31 13is of concern since it could lead to tissue heating (1-5). In P and C-MR 
spectroscopy an H decoupling RF field often is applied during the data 
acquisition period to remove multiplet splittings for improved sensitivity and
13 1 13resolution (6-8). Especially in C-MRS where relatively large H- C couplings 
have to be removed this may pose problems as the specific RF absorption rate 
(SAR) may exceed safety limits.
To estimate the SAR for volume coils their spatial RF distribution can be 
evaluated by computational techniques. The impedance method which uses 
anatomical models has been described for the human torso (9, 10) and for the 
human head (11). In another approach geometrical models have been used (5, 
12).
1 13For H decoupling in C-MRS mostly surface type coils are used. In contrast to 
volume coils, calculation of the local SAR is complex with these coils. Because of 
the inherent RF field inhomogeneity of surface coils, the local SAR will sooner 
exceed the safety guidelines (2) than the average SAR in the sensitive region of 
the coil. Several attempts have been made to estimate the SAR by 
computational techniques for the use of surface coils (12-16).
For patient safety, it is absolutely necessary to evaluate the local SAR for every
1 13applied experimental condition of H decoupling in C-MRS. In this study we 
describe an experimental approach that matches the experimental conditions 
applied during decoupling to estimate the local SAR instead of using a 
computational model.
The basis of our approach is a pulse sequence which is well known in high
13resolution C NMR to calibrate the decoupler field strength (17). Extended with 
phase encoding this sequence provides spatial information about the RF field 
distribution of the decoupler coil (18). The spatial information of the decoupler RF 
field strength obtained by this technique, can be used to optimize the decoupler 
field strength and to calculate the local (surface) SAR.
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Materials and Methods
Measurements were performed on an 1.5 T Magnetom SP 4000 (Siemens, 
Erlangen, Germany) equipped with a second RF transmit channel. Double 
resonance experiments were performed using a double surface coil consisting of
13 1an 11 cm diameter C surface coil and a 17 x 23 cm H butterfly coil. The slightly
1 13“V” shaped H coil was placed below the C coil to avoid the high flux regions of 
the coil wires near the patient. The patient to coil distance was 32 mm in the 
center and 16 mm at the outside of the coil. Dielectric losses in the distant 
patient volume were further minimized by using a transmission line resonater coil 
with distributed tuning capacitance (19). The H coil was cooled by airflow to 
prevent possible mismatching caused by heating the coil due to power deposited 
in the coil during decoupling.
To evaluate whether the SAR remains within safety guidelines it is necessary to 
know the highest local SAR. The highest local SAR with the use of surface coils 
is assumed to occur at the body surface closest to the surface coil. To estimate 
this time averaged superficial SAR (Ssup) we used equation 1 (7).
During a decoupling experiment the peak power actually applied to the surface
S sup =  [ P used/Ps0p ] x  S tis x  D C  [1]
coil (Pused) and the pulse duty cycle (DC) are known. So the time averaged SAR 
at the body surface (Ssup) can be calculated if the Ps9ü, which is the peak power
ti sapplied to the surface coil to obtain a 90° pulse at the body surface and S the 
specific power absorbed by the tissue are known.
The latter one was determined for a 90° pulse of 500 ^s (WALTZ element) in a 
homogeneous RF field using equation 2.
S tis = (1 -Q l/Q u ) x  P total /  W total [2]
ti sTo obtain the S value we used a regular knee coil linearly polarized, and placed 
a certain amount of fresh meat (weight: Wtotal) in it. The quality factor (Q) of the 
coil was determined loaded (Ql) and unloaded (Qu) with a network analyzer 
model 8752A (Hewlett Packard, Santa Rosa, California). Power applied to the 
coil (Ptotal) was measured using a powermeter model 8542B supplied with
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80350A peak power sensors (Giga-tronics Inc., San Ramon, California). Cable 
losses were measured and corrected for.
With the use of efficient transmitter coils, as done in this study, dielectric losses 
are considered to be negligible, and thus the power absorbed by the tissue is 
mainly due to the induced electric field which arises from the magnetic field (2, 5, 
12). It is assumed that whenever the B1 field strength is equal at a location in the 
homogeneous coil and at a location in the sensitive region of the surface coil the 
SAR will also be equal. To assess P90, the pulse power needed for a 90° H flip 
angle at a certain location, we modified a sequence previously described by Bax 
(17). The original sequence enables one to calibrate the decoupler RF field 
strength. However, this calibration is not spatially resolved. In our modified 
sequence we use phase encoding to perform localized calibration of the 
decoupler RF field strength (18).
Phase encoding
----------------# ----------------------------
Figure 1
Schematic representation of the spatial RF field calibration sequence. The delay A has to be set 
1/(2J) of a directly bonded 13C-1H pair. At the location where the proton pulse flip angle Q equals 
p/2, no carbon magnetization will be observed for the 13C resonance of the 13C-1H pair.
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A schematic representation of this modified sequence is given in figure 1. The 
delay A has to be adjusted to 1/(2J), where J is the H carbon spin coupling
13 1constant for a directly bonded C- H pair. In the region where the proton pulse 
flip angle 0  equals p/2, no carbon magnetization will be observed for the carbon
13 1resonance of the C- H pair, so it’s easy to assess the P90 for this region.
13The C doublet signals at ± 128 ppm of unsaturated triglycerides in superficial
13 1adipose tissue were used as the C- H pair for in vivo estimations of the 
superficial 90° peak power. In order to obtain these Ps9ü values, we acquired at 
least four 1D-CSI measurements with different peak powers applied to the 
surface coil. These measurements were performed for the head, liver, muscle 
gastrocnemius and muscle vastus lateralis from 5 different healthy volunteers 
after receiving a written informed consent. Mean age of the subjects was 28 yr. 
(range 22-46 yr.), body mass 73 kg (63-90 kg).
Measurement parameters of the calibration 1D-CSI were as follows, 32 phase 
encoding steps, a field of view of 160 mm resulting in slices of 5 mm, a repetition 
time of 400 ms, total number of acquisitions 1280, 1024 datapoints were 
acquired, A was set to 3.289 ms which corresponds to 1/(2J) of the unsaturated 
triglycerides. The pulse duration of the H pulse on the second RF channel was 
500 ms.
On a cylindrical phantom with diameter 14 cm, containing sunflower oil, 3D-CSI 
calibration measurements were performed and in addition B1 field map images 
(11) were made in three orthogonal planes of a rectangular container 14 x 27 x
37 cm (h x w x l) filled with water, both to obtain information about the RF field 
distribution of the H decoupling coil in 3 dimensions.
To verify the correlation between the calibration and decoupling performance we 
used the cylindrical phantom. The settings for the decoupling 1D-CSI matched 
the settings of the calibration sequence, decoupling was performed with WALTZ- 
4 with a basic 90° pulse of 500 ms, corresponding to a decoupling field yB2/2p =
13500 Hz. The proton bandwidth with these settings over which the C-MRS 
resonance peak from unsaturated triglycerides remains within 85% of its fully
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1decoupled value was determined to be ±400 Hz which is sufficient for H 
decoupling at 1.5 T.
Spectral data were analyzed using the Luise software (Siemens, Erlangen, 
Germany). CSI data were zerofilled in spatial as well as spectral dimension to a 
64 x 2048 matrix. The CSI voxels were shifted to match with the superficial 
adipose tissue. Unsaturated triglyceride signals of superficial adipose tissue were 
fitted and integrated. Integrated areas of resonances multiplied by their peak sign 
were plotted against the RF peak power applied to the decoupler surface coil and 
the zero-crossing was chosen as the value for the Ps9q.
175 150 125 175 150 125
chemical shift (ppm)
Figure 2
(a) Stack plot of spectra obtained with the 1D-CSI RF field calibration sequence from a cylindrical 
phantom filled with sunflower oil. The delay A was set to 1/(2J) of the unsaturated 13C-1H pair of 
triglycerides from sunflower oil. 13C-MR spectra were collected from 0.5 cm slices. (b) Stack plot of 
spectra collected with a corresponding 1D-CSI using WALTZ-4 decoupling. The same peak power 
was applied to the decoupler coil in the calibration sequence and during WALTZ-4 decoupling.
Results
13Figure 2a. shows 1D-CSI C-MR spectra obtained with the spatial RF calibration 
sequence from the cylindrical phantom filled with sunflower oil. In this stack plot 
42
1 13Experimental evaluation of the SAR in H decoupled C MRS
one can clearly see that in the slice at a depth of 4 cm there is almost no 
magnetization left, the H pulse flip angle 0  in this region is approximately p/2. In 
the region closer to the coil the H pulse angle 0  > p/2. Further away from the 
coil (4.5 cm) the pulse angle generated by the decoupler coil is less than p/2. If
13we look at the corresponding 1D-CSI C-MRS measurement with WALTZ-4 
decoupling at the same proton RF peak power (figure 2b.) one can see that the 
decoupling performance close to the coil is excellent. Beyond the region where 
the H pulse angle 0  is estimated to be p/2 with the use of the 1D-CSI calibration 
sequence, we can see sidebands appearing due to insufficient decoupling 
power. This shows that RF calibration and decoupling performance are in good 
agreement.
tisThe average S (equation 2.) measured with a regular knee coil of fresh meat 
samples was found to be 9.09 Watt/kg (SD= 1.36, n=4).
peak power (Watt)
Figure 3
Integrated areas of the unsaturated triglyceride signals multiplied with their peak sign plotted against 
the RF amplitude of the decoupling channel.
Spectra were obtained from the head of a healthy subject, placed with the occipitoparietal region 
facing the surface coil. Four 1 D-CSI measurements were performed with different peak power on 
the decoupler RF channel. Spectra originating from the subcutaneous adipose tissue were 
analyzed.
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1In figure 3 the results of a RF calibration of the H decoupling coil loaded with the 
human head are presented. The data are obtained from four different 1D-CSI 
calibration measurements, all with different peak power on the decoupler RF 
channel, taken from the slice matching with the superficial lipid tissue (in this 
case of the human head). From this graph one can easily derive a value for Ps9o. 
Similar studies were performed for liver and skeletal muscle. Averaged values 
from 5 healthy volunteers of the Ps9o for these tissues are given in table 1.
The data obtained from the cylindrical phantom, filled with sunflower oil, with the 
3D-CSI calibration sequence showed a much larger variation in pulse angle as a 
function of distance from the coil compared to variations in pulse angle in a plane 
parallel to the coil.
Tissue min. max. mean
(n=5)
SD
head 5.01 5.85 5.49 0.35
liver 9.06 14.95 11.79 2.35
muscle vastus lateralis 7.15 11.78 9.01 1.99
muscle gastrocnemius 5.28 6.80 6.06 0.71
Table 1.
Mean Psg§ (Watt) values from 5 healthy subjects, obtained with the 1 D-CSI calibration sequence 
from the head, liver, muscle vastus lateralis and muscle gastrocnemius.
When the power was set to achieve an excitation pulse angle of 90° in the 
second plane parallel to the coil with the use of the 1D-CSI calibration, the voxels 
in the bottom plane all showed excitation angles larger than 90°. The voxels in
13 1the second plane all showed very small signals or no signal at all for the C- H 
pair, meaning an excitation angle close to 90°. The voxels in the third plane all 
showed an excitation angle less than 90°.
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B1 field maps reconstructed from images of the large rectangular phantom, filled
13with water and placed on top of the C surface coil gave a more detailed picture 
of the relative field strength within the excitation volume of the decoupling coil. 
The field maps perpendicular to the plane of the coil showed a decreasing B1 
field moving away from the coil as in figure 2. A “butterfly” shaped field map
13image was obtained in a 6 mm thick slice adjacent and parallel to the C coil. 
The latter field map showed three regions with slightly increased intensity. These
13regions were connected with each other, with one at the center above the C 
surface coil and with two side lobs above both loops of the H coil. Setting the 
pixel with the highest B1 field strength to 100 % resulted in an average B1 field 
strength of 91.8 % (SD = 2.45 %) for a large rectangle, 212 x 100 mm covering 
the 3 regions, which indicates a fairly uniform B1 field distribution. The average
13B1 field of the decoupler coil within the sensitive area of the C coil ( a circle with 
diameter 100 mm) was 90.6 % (SD = 2.41).
used 13The actual power used (P ) to acquire broadband decoupled C-MR spectra 
of the tissues studied in this paper, resulted in Pused/ Ps9Q values ranging from 1 
for superficial lipid to 11 for the liver. Using formula 1 one can calculate duty 
cycle values to remain within safety guidelines for the local SAR (2) to be 0.88 
and 0.08 respectively. For signals like the C1 of glycogen in muscle or liver an 
adequate signal to noise ratio can be achieved with these duty cycles within 
acceptable measurement times (20).
Discussion
1In this paper an experimental method to obtain spatial information of the H
1 13decoupling RF field strength in H decoupled C-MRS is presented. With this 
method the minimum power needed to obtain adequately decoupled spectra can 
be determined. Furthermore the calibration procedure makes it possible to obtain 
exact values of the power needed to generate a 90° excitation angle at the 
surface and thereby enabling a local (surface) SAR calculation.
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Localization for this calibration procedure was performed in only one direction 
parallel to the surface coil. With phase encoding in only one direction we were 
able to acquire four data sets with a good signal to noise ratio with respect to the 
unsaturated triglyceride signals within acceptable measurement times. To justify 
the use of 1D-CSI calibration of the decoupling RF field strength, we had to 
assume that the RF field strength of our decoupling coil varies more in depth 
than in a plane parallel to the coil. This assumption was verified with a 3D-CSI 
calibration experiment performed on the cylindrical phantom containing 
sunflower oil. The results from this 3D-CSI experiment showed that the in plane 
variation was small compared to the variation between planes parallel to the coil. 
Similar results were obtained by using a B1 field map imaging technique.
These B1 field map images show some similarity with the computer contour plots 
of the magnitude of the transverse RF field produced by a 8 x 13 cm figure eight 
surface coil (12), notwithstanding the difference in coil sizes and shape.
Although the B1 field map imaging technique can give quick access to the RF 
field distribution of a coil in several orientations, it only gives relative information 
about the RF field distribution. In this study we need to know the amount of 
power to apply to the surface coil to generate a 90° pulse at a certain location 
and this information can exactly be obtained with the calibration procedure.
A possible limitation of the SAR estimation procedure is that it evaluates the
13sensitive area of the C surface coil, and thus may overlook higher field 
strengths of the decoupler coil outside this area to which the subject may be
13exposed. However, the B1 field maps obtained in a plane adjacent to the C coil 
from a phantom extending well beyond the viewing area of the H coil showed 
that, for the current used coil configuration, the B1 field strength the in region 
used for the SAR estimation deviated less than 10 % from the most intense spot 
of the B1 field of the decoupler coil. Furthermore, in actual in vivo H decoupling 
experiments the subjects tissue is positioned in such a way that its only exposed 
to the central region of the B1 field of the decoupler coil.
In this study we used the superficial adipose tissue to estimate the Ps9o and used
ti sequations 1 and 2 to calculate the local (surface) SAR. To obtain S we used 
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fresh meat which mainly contains muscle tissue whose conductivity is higher 
than that of adipose tissue (10). In this way we may overestimate the local SAR 
for superficial adipose tissue. However care should be taken because of the skin 
adjacent to the superficial lipid (closer to the surface coil) whose conductivity is 
similar to that of muscle.
The RF field inhomogeneity of circular surface coils leads to an inefficient use of 
RF power used for decoupling (21). This is also true for the butterfly coil used in 
the present experiments, as shown by the high Pused/ Ps9Q ratios. With different 
coil configuration types it maybe possible to make more efficient use of the 
power applied to the decoupling coil(22).
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Abstract
The thermoregulatory response of the skin was investigated in 5 healthy 
volunteers during prolonged exposure to RF radiation by a surface coil. 
Temperature changes induced by RF radiation were measured at the skin of the 
calf muscle by a fluoroptic probe. Exposure to superficial SAR levels of 6.5, 12 
and 22 Watt/kg resulted in skin temperature increases, the highest temperature 
recorded was 38.3 °C. Although the maximum values of each temperature curve 
correlated with the applied superficial SAR levels, these values did not exceed 
the recommended temperature limit for the extremities such as given by the 
FDA. None of the subjects experienced the changes in skin temperature. For 
subjects with normal thermoregulatory function, these findings suggest that the 
recommended SAR limit for the extremities may be too conservative.
This chapter is based on a paper submitted to Magnetic Resonance in Medicine.
Chapter 3
Introduction
Proton decoupling and nuclear Overhauser enhancement (NOE) are often
13 31applied in in vivo C and P MR spectroscopy in humans (1-6). Benefits of 
these techniques are, improvement of spectral resolution (spectrum 
simplification) and improvement in signal to noise ratio. A better signal to noise 
ratio means that measurement time can be reduced, which is important for 
patient comfort.
However, proton decoupling and NOE require relatively high level RF radiation 
often applied with high duty cycles. Heating, induced by this RF radiation during a 
MR examination, is of concern because of possible tissue damage (7-11).
13Precautions should be taken in experimental procedures, especially in C MRS,
1 13in which relatively large H- C couplings have to be removed (1, 2, 5, 12, 13).
13To perform a C in vivo MR spectroscopy experiment, a coil configuration is
13 1required with the highest possible sensitivity for C, and an efficient H coil for 
decoupling. Therefore, often surface coils are used (1, 4, 14-16). Because of the 
inherent RF field inhomogeneity of these type of coils, they produce a high local 
specific absorption rate (SAR) and a low total body SAR. Recently, we developed 
an empirical procedure to predict the local SAR at the body surface, for surface 
coils using the unsaturated carbon signals of subcutaneous lipid tissue (17). 
However, power deposition in the skin is not directly evaluated by this method. 
The skin probably reflects the worst case because of its properties and its 
position in the RF field of the surface coil.
Either SAR levels or temperature criteria can be used as guidelines for safety 
precautions (18). Several animal and human studies have been performed to 
study the temperature increase at different locations on the body during imaging 
protocols using a body coil (19-22). Temperature changes by a proton 
decoupling protocol using a surface coil were reported by Morvan et al. (23). In 
the latter study temperature changes were measured by an imaging technique, 
based on the temperature dependence of the diffusion coefficient of water. 
Temperature change was measured in muscle tissue after 20 minutes of
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decoupling. To our knowledge, measurements of absolute skin temperature 
during decoupling have not yet been reported.
The aim of the present study was to investigate if exposure to high local SAR 
levels applied with a surface coil could result in skin temperatures above the 
recommended criteria for safe MR operation (18).
Experimental
Subjects. Five healthy male subjects participated in this study. Subjects were 
screened for contra-indications to undergo a MR procedure. All subjects were 
experienced MR investigators and were well aware of the possible tissue heating 
effects of high level RF radiation. The subjects were in contact with the MR 
operator during decoupling experiments; experiments could be terminated at any 
time.
System. Experiments were performed at 1.5 T using a Siemens Vision whole 
body system (Siemens, Erlangen, Germany) supplied with a second RF transmit 
channel. We used a double surface coil configuration consisting of an 11 cm
13diameter C coil and a 17 x 23 cm butterfly proton coil. The slightly V-shaped
13proton coil was placed below the C coil to avoid the high flux regions of the coil 
wires near the patient. This coil was cooled by air flow to prevent possible 
mismatching caused by heating the coil due to power deposited in the coil during 
decoupling. The ambient conditions were: room temperature 21 ± 1.0 ° C, relative 
humidity between 50 % and 70 %.
Subjects laid in a supine position with the calf muscle of the right leg positioned 
on the double surface coil. In total 4 experiments were performed on each 
subject. The first experiment was to determine the Ps9o, which is the power 
applied to the surface coil to obtain a 90° pulse at the body surface (superficial 
lipid tissue). This was done by a spatially resolved calibration sequence 
according to (17). In order to obtain information of the thermoregulatory function 
of the skin during exposure to RF radiation, 3 subsequent experiments were 
performed at different occasions with respectively 6.5, 12 and 22 Watt/kg local
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SAR (Ssup) deposited as determined for subcutaneous adipose tissue. This 
superficial SAR value for each individual was calculated using Eq. 1 (1, 17).
s sup =  [ P used/ P - p ] x  S tis x  D C  [1]
tisThe specific absorption of muscle tissue S was determined to be 9.09 Watt/kg 
for a 500 ms rectangular 90° pulse (17). The value for Pused and the duty cycle 
(DC) can be set to desired values. In the current study, the DC was fixed at 27 % 
and Pused was changed to achieve the required superficial SAR value.
The subjects were inside the magnet for approximately 10 minutes prior to the 
start of decoupling. During this period imaging and shimming was performed and 
the temperature of the skin could stabilize.
During the 60 minutes that each decoupling experiment lasted the skin 
temperature of the muscle gastrocnemius at the center of both coils, which 
reflects the worst case, was monitored with a fluoroptic thermometry system 
(Luxtron 712, California, USA). A control fluoroptic probe was attached to the 
skin of the same leg at the muscle quadriceps femoris outside the RF field of the 
double surface coil. Temperature was sampled with 30 second time intervals. 
The fluoroptic probes were attached to the skin with micropore tape. 
Temperatures at the start of each experiment were determined for both 
temperature probes. The maximum skin temperature (Tmax) and the temperature 
at the end of each experiment (Tend) were derived from the temperature curves.
Results
The amplitude required for a 500 ms 90° pulse at the body surface ranged from 
6.7 to 7.8 Watt (mean ± SD; 7.2 ± 0.47 Watt).
The mean skin temperature at the start of the decoupling periods was 30.23 ± 
0.63 °C. This temperature was lower than the mean control temperature at the 
start of the decoupling experiments, which was 33.56 ± 0.78 °C. This difference 
was due to the cooling of the coil on which the leg was positioned.
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tim e (minutes) time (minutes)
Figure 1.
Figure A, experimental data of subject 2, skin temperature increase of the calf muscle during 60
minutes of decoupling with different local (superficial) SAR levels, —  6 .5 ,-------- 12 a n d -------- 22
Watt/kg. Figure B, experimental data of skin temperature overshoot at 22W/kg local SAR of three
subjects: —  subject 3 , --------subject 4, and --------subject 5. Temperature was monitored with time
intervals of 30 seconds using a fluoroptic probe attached to the skin.
At the onset of decoupling the skin temperature within the RF field rapidly 
increased in all experiments, at all power levels. During further decoupling the 
temperature rise slowed down. In most experiments the temperature curve 
occurred as an one phase exponential as illustrated in figure 1A for an individual 
subject. Fitting the experimental data of this subject with an one phase 
exponential function resulted in R values > 0.99. In these cases the Tend 
corresponds with Tmax. The relation between the applied power level and the 
maximum temperature reached is clearly visible in this figure. The initial 
temperature rise is also higher at higher local SAR levels.
In three experiments, all with the highest local SAR applied, the temperature 
curves followed a different shape, see figure 1B. Skin temperature first 
increased, followed by a decrease after which it stabilized.
Summarized results for each individual and for each SAR level are given in the 
table 1. In figure 2, the relationship between the applied superficial SAR and the 
Tmax is shown. This relation between local SAR and Tmax is not linear. Since for
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three individuals the Tend at the superficial SAR level of 22 Watt/kg was different 
from the Tmax, this value is also shown in figure 2.
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Figure 2.
Mean and standard deviation (n=5) of the Tmax (■) during a proton decoupling protocol applied to the 
calf muscle plotted against superficial SAR level. Tend value ( • )  is shown for the superficial SAR 
level of 22 Watt/kg.
None of the subjects experienced any tissue heating effects, nor did they report 
any other discomfort during the decoupling procedures.
In 12 out of 15 experiments the control skin temperature recorded outside the RF 
field of the proton decoupler coil fluctuated in a range of ± 0.5 °C, with no clear 
increase or decrease. Three cases showed a clear rise of the control 
temperature during decoupling, of which the largest was 1.8 °C, during an 
experiment with 6.5 Watt/kg superficial SAR.
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Subject Age
(year)
body
weight
(kg)
DsupP90
(Watt)
22 W/kg
Tmax Tend
12 W/kg
Tmax
6.5 W/kg
Tmax
1 31 85 7.1 36.8 36.8 37.0 34.6
2 26 75 6.8 36.4 36.4 35.1 32.6
3 49 87 7.9 38.1 37.8 35.6 33.1
4 33 65 7.5 38.3 37.9 35.1 33.1
5 26 87 6.7 37.4 37.2 35.2 33.1
Table 1.
Subject information and summarized results of the calibration and decoupling experiments. PfO 
values are given for each individual as well as Tmax and Tend values for the three applied superficial 
SAR levels.
Discussion
In this study the effect of RF radiation by an H decoupling coil on the skin 
temperature was investigated. The duration of the applied decoupling is
1 13representative for several consecutive H decoupled C MR spectroscopy 
examinations such as in dynamic studies.
The RF radiation by the H surface coil during decoupling induced changes in 
temperature that could be described by an one phase exponential increase in all 
except for three experiments. In three subjects, at the highest superficial SAR 
level the temperature curve showed an overshoot. The Tmax in these three 
subjects was higher than 37 °C, in the other two subjects the Tmax remained 
below 37 °C at the same superficial SAR level.
Thermophysiological responses are difficult to predict; several studies report on 
whole body thermophysiology (24-27). Studies on local tissue temperature stress 
suggest that the heat removed from or supplied to the tissue by blood circulation 
is one of the most important factors in thermoregulation (28-30). Heat induced by
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RF and heat loss to the environment also play a major role in the local tissue 
heat balance, conductive heat transfer through tissue and metabolic heat 
production are less important (28, 29, 31).
It goes beyond the scope of this study to model the temperature curves. Similar 
increments in skin temperature as observed in this study could be accounted for 
by Buse et al. in an one-dimensional mathematical model study (32). Overshoots 
above the core temperature as in the present study were also described. The 
weighting factor of the skin temperature feedback and the depth of the skin 
receptors could be modeled to match the experimental data (32).
A steady state skin temperature is reached in most experiments, at that time, 
there is an equilibrium between heat induced by RF irradiation and the total heat 
loss. Higher local SAR levels result in higher equilibrium skin temperatures. 
When skin temperature rises above the core temperature, heat removal by the 
blood circulation and (local) sweat production starts to play an important role, 
and a non-linear relation between the locally applied SAR and the equilibrium 
skin temperature is expected as seen in figure 2.
Morvan et al. reported a temperature increase in muscle tissue close to the skin 
of 5 °C after 20 minutes of decoupling at a level of 6 Watt input power (23). It is 
not clear to what level of superficial SAR this corresponds. As shown in figure 1, 
the temperature increase did not reach a steady state within 20 minutes in our 
experiments. The temperature overshoot, as observed in our experiments, 
demonstrate that it is also important to monitor temperature during decoupling. 
Furthermore, the temperature registered by imaging was obtained within 1 
minute after cessation of decoupling, our data (not shown here) showed a 
decrease in temperature of 0.5 °C within the first minute after cessation of 
decoupling.
Locally we measured a rather large temperature increase as a result of RF 
radiation applied with a surface coil. It is not likely that these experiments will 
result in an increase in core temperature. The highest total average body SAR in 
our experiments was 0.15 W/kg. No statistically significant differences in mean
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body temperatures were reported by Shellock et al. during a 30 minute MR 
imaging protocol with up to 4.0 W/kg mean SAR (20).
Despite the relatively large increase in skin temperature, none of the subjects 
sensed these changes. Skin temperature can change during the circadian 
rhythm or in response to the environment in a broader range than detected 
during this study (33).
These findings that at SAR levels above the spatial peak power level of 8 W/kg 
recommended by the FDA do not result in temperature increase above 40 °C 
which is temperature limit for the extremities (18), suggest that recommended 
RF radiation safety levels for MRI/MRS procedures may be too conservative in 
humans with normal thermoregulatory function for the extremities. Previously this 
has been discussed for whole body procedures in (20). For comparison, the 
metabolic rate of humans is 1.5 W/kg during sleep, 5 W/kg during moderate 
exercise and 15 W/kg for very heavy exercise, so the locally applied SAR values 
in this study (which corresponds with a maximum body average SAR of 0.15 
Watt/kg) are not that extreme (10).
However care should be taken because a given SAR can result in different 
temperature increases depending on the type of tissue and blood flow. Especially 
in patients with a diminished thermoregulatory function as in diabetes, obesity or 
cardiovascular disease. Therefore, temperature changes seem to be a more 
direct indication for possible tissue damage. (20, 21, 23).
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Abstract
1 13The potential of heteronuclear { H- C} cross polarization was studied for
13optimization of the signal to noise ratio in in vivo C MR spectroscopy at the 
clinical field strength of 1.5 T. Experiments on the human calf showed a 
significant chemical shift selective signal enhancement on triglyceride signals of 
3.9 by heteronuclear cross polarization, compared to a standard pulse-acquire 
sequence. Studies on a neonatal piglet brain showed an enhancement by cross
13polarization of 2.2 for the detection of C-1-glucose. This enhancement allowed
13 13a fourfold improvement in time resolution in dynamic C MR of C-1-glucose 
inflow in piglet brain. Phantom experiments demonstrated the efficiency of this 
technique for interleaved detection of two spectral regions. Tests with a volume 
coil showed the feasibility of signal enhancement by cross polarization over a 
large volume of interest.
This chapter is based on the publication: Heteronuclear cross polarization for enhanced sensitivity of 
in vivo 1 C MR spectroscopy on a clinical 1.5T MR system. A.J. van den Bergh, H.J. van den 
Boogert, A. Heerschap, J Magn Reson, 135: 93-98 (1998)
Chapter 4
Introduction
13In vivo C MR spectroscopy enables one to obtain metabolic information of 
humans not easily obtained by other non-invasive methods. The large chemical
13shift range of C MR spectra allows the resolution of resonances of a large 
number of substances, and thereby the study of some metabolites of which the 
signals are difficult to resolve in H MR spectroscopy.
13One of the major drawbacks of C MR spectroscopy applied to humans is its low 
sensitivity, that is a consequence of the low natural abundance (1.1%) and the
1 13low gyromagnetic constant g of the carbon nucleus ( g H / g C » 4). Furthermore, 
most carbons have attached protons, resulting in multiplet structures which 
further decrease sensitivity and complicate spectrum analyses.
13Most C MR studies performed on humans use proton decoupling to remove the 
multiplet-splittings, thereby enhancing sensitivity and resolution (1-5). With
13nuclear Overhauser enhancement (NOE) the sensitivity of C MR spectroscopy 
can be further increased (6-8).
Heteronuclear polarization transfer provides another way to enhance sensitivity. 
This polarization transfer can be performed from the sensitive to the insensitive 
nucleus or vice versa (9, 10). The theoretically highest signal gain can be 
obtained when excitation and detection are performed at the sensitive nucleus 
(11-15).
This study focuses on the polarization transfer from protons to carbons to 
enhance sensitivity. Only a few studies have been reported in which this was
13applied to in vivo C MR spectroscopy of humans, e.g., by the SINEPT method 
(16, 17) and by the DEPT method (18, 19). An alternative approach, not based 
on pulse-interrupted free precession, but by which transfer of magnetization is 
achieved by heteronuclear isotropic mixing, has recently been reported to be 
feasible in vivo at high magnetic field on a small bore NMR system (20). An 
adiabatic variant of this heteronuclear cross polarization has been proposed for 
in vivo applications (21). The technique of heteronuclear cross polarization has
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some advantages compared to the pulse-interrupted free precession methods: 
(i) the resulting peaks are not in mixed phase as may occur in SINEPT which 
makes analyses of the signals easier; (ii) the magnetization transfer function is 
less critically dependent on the scalar coupling; (iii) in the DEPT sequence strong 
180° refocusing pulses are used, which are often a source of artifacts in the case 
of inhomogeneous B1 fields; (iv) the transfer does not depend on the multiplicity 
like in DEPT; (v) relaxation losses during the magnetization transfer period are 
limited (20); (vi) one can use decoupling without the need for a delay (which 
results in a further decrease in enhancement) between the polarization transfer 
pulses and the decoupling / acquisition period as in SINEPT (16).
1 13The objective of this study was to explore the potential of heteronuclear { H- C} 
cross polarization, using a WALTZ isotropic mixing period, to enhance the
13sensitivity of C MR spectroscopy on a clinical MR system at 1.5 T. The 
WALTZ-4 based cross polarization sequence is shown in figure 1.
1H 90°
WALTZ-4 decoupling
Figure 1.
The WALTZ-4 based heteronuclear cross polarization sequence. Duration of the WALTZ-4 contact 
pulse was 6.5 ms, which is optimal for proton-carbon coupling constants of 150 Hz.
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Experimental
Measurements were performed on an 1.5 T Magnetom SP 4000 (Siemens, 
Erlangen, Germany) equipped with a second RF transmit channel. Two types of
13 1coil configurations were used for the different C / H double resonance 
experiments, depending on the volume of interest. The surface coil set-up
13consisted of an 11 cm diameter C transmit / receive surface coil and a 17 x 23
1 1  cm H transmit / receive butterfly coil. As a volume coil an H linear vertically
polarized birdcage constructed within the original housing of a Siemens SP head
13coil was used, combined with a transmit / receive C horizontally polarized 
curved half volume coil (22).
13Two pulse sequences were used in this study. First, a C pulse-acquire 
sequence with optional proton decoupling during the acquisition period and 
secondly a cross polarization sequence as described in (23). The mixing period 
in the latter sequence consisted of one WALTZ-4 cycle with a duration of 6.5 ms, 
decoupling was also optional in this sequence.
For the direct detection experiments the power of the hard 260ms excitation pulse 
was optimized for maximal signal intensity. This optimized power level was also 
used for the contact pulse in polarization transfer experiments. The RF field 
strength of the H coil for decoupling as well as polarization transfer was 
optimized for a certain volume using a localized calibration technique (24) which 
enables optimal settings for polarization transfer despite the use of two differently 
shaped coils.
Phantom studies
To demonstrate the feasibility of this sensitivity enhancement technique several 
phantom studies were performed. To test the surface coil set-up we used a 
cylindrical phantom with diameter 10 cm, containing sunflower oil, or a solution of 
109 mM glycosyl units rabbit liver glycogen. Another phantom spherical in shape, 
with diameter 8 cm, contained a solution of glucose, lactate and glutamate. The
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latter phantom was used to study interleaved cross polarization at two different 
frequencies.
To investigate the effect of the larger matching volume of the RF fields of the 
volume coil set-up we used a large spherical phantom (diameter 15 cm) filled 
with sunflower oil. Localized spectra were acquired using 2 dimensional chemical 
shift imaging (CSI); the phase encoding was applied after the polarization
1 13 13transfer from H to the C nucleus to compare the results with conventional C 
2D-CSI measurements.
In vivo studies
Postmortem decoupling and cross polarization studies were performed with the
13surface coil set-up on a neonatal piglet brain, containing C-1 labeled glucose,
13to optimize the Hartmann-Hahn matching. In vivo C MR spectroscopy was 
performed on the brain of an anesthetized neonatal piglet to monitor the influx of
13labeled C-1-glucose. The piglet was anesthetized with pentobarbital, and 
catheterized in the carotid artery. Inside the magnet, anesthesia was maintained 
by pump-ventilating with ethrane. During spectroscopy, rectal temperature and 
ECG were monitored. Over a period of 15 minutes, glucose 20 % (30% enriched) 
(Campro Scientific, Veenendaal, The Netherlands) was infused with an 
infusion speed of 0.5 ml/min. In this case cross polarization was performed at 
one frequency region to achieve the highest time resolution possible.
13Furthermore, C MR spectra of the human calf were obtained to show that 
signal enhancement using cross polarization is realizable on humans in vivo. In 
this experiment, the SAR at the body surface of RF power deposition from the H 
surface coil was estimated to be 2.9 Watt/kg, as calculated according to the 
procedure described in (24) and this is well below safety guidelines (25). This 
SAR value was mainly due to the decoupling part of the sequence, and not the
13WALTZ-4 contact period. Contribution of the C channel was negligible because 
of the much lower duty cycle and its lower frequency (26).
Spectral analyses was performed using Siemens Luise software (Siemens, 
Erlangen, Germany). Spectra were zero-filled to 4K data-points, multiplied by a
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gauss function of 64 ms, phase and baseline corrected, peaks of interest were 
fitted to a gaussian lineshape. Chemical shift imaging data were filtered with a 
hamming filter prior to fourier transformation. Spectra of individual voxels were 
analyzed as mentioned above.
Chemical shift scaling was performed placing the methyl signal of 
tetramethylsilane at 0 ppm.
ß/a C-1 glucose C-3 lactate
100 75 50 25
ppm
Figure 2.
13C MR spectra recorded from a spherical phantom containing an aqueous solution of glucose 300 
mM, lactate 250 mM and glutamate 200 mM. Shown are spectra obtained with a pulse-acquire 
sequence (A) compared to spectra (B, C) obtained with chemical shift selective cross polarization. 
Measurement parameters were as follows: 256 FIDs were accumulated for spectrum (A), for spectra 
(B) and (C) in an interleaved fashion: 2 times 2 blocks of 128 accumulations at each frequency, the 
13C frequency was placed at the C-1-glucose region (94 ppm) and at the C-3-lactate region (20 ppm) 
with a difference of 1200 Hz. Spectral width was 8 kHz, 512 datapoints were collected, and the 
repetition time was 1 s.
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Results
Phantom studies
1 13Figure 2A shows an H decoupled C MR pulse-acquire spectrum of a phantom 
filled with an aqueous solution of glucose, lactate, and glutamate, obtained with a 
surface coil set-up. Resonances of carbon spins from all substances are clearly 
visible. Spectra in figure 2B and 2C show the results of the enhancement by the 
use of chemical shift selective cross polarization applied in an interleaved mode 
for two specific spectral regions, i.e., at the C-1 resonance of glucose (94 ppm) 
and at the C-3 resonance of lactate (20 ppm). Enhancement factors of both 
resonances were 3.1 and 3.6, respectively. The present use of WALTZ-4 based 
cross polarization makes the experiment chemical shift selective; polarization 
transfer occurs in a small spectral region (yB1/2p » 900 Hz). Cross polarization 
experiments targeting a single frequency region were performed with the surface 
coil set-up on phantoms containing sunflower oil and a glycogen solution. On the 
oil phantom enhancement factors of 3.8 for the unsaturated as well as the 
saturated lipid carbon resonances could be achieved, which is close to the 
theoretical maximum enhancement of » 4. The signal gain of 2.1 obtained for the 
C-1 signal of glycogen in solution was considerably lower.
13Experiments with the volume coil and C MR spectroscopy acquisition extended 
with 2D-CSI localization resulted in the data presented in figure 3. Spectral maps 
of the C=C spectral region at 130 ppm of the 2D-CSI data sets are shown; the
1 13spectra drawn in white were obtained with H broadband decoupled C 2D-CSI. 
Spectra drawn in red were obtained with the polarization transfer pulse sequence 
optimized for the C=C spectral region; broadband H decoupling was also 
applied.
All voxels showed a significant signal increase, signal gains of the individual 
voxels ranged from 2.68 to 3.85, mean signal gain was 3.18 (SE = 0.04). The 
lowest signals in both experiments are in the top row voxels. These voxels are
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13outside the sensitive volume of the C half volume coil which was wrapped 
around the bottom side of the phantom; coil wires are marked in the figure.
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Figure 3
Spectral maps obtained from a large spherical phantom containing sunflower oil, measured using an 
1H / 13C volume coil configuration. Spectra acquired using heteronuclear cross polarization are 
drawn in red, compared to the spectra obtained with a pulse-acquire technique shown in white, 
plotted with the same scaling. Positions of the 13C half volume coil wires are indicated.
The matrix size of the CSI data was 16 x 16 x 1024, spectral width was 6 kHz, field of view of 240 
mm resulting in a voxel size of 15 x 15 mm, repetition time in both puls-acquire and heteronuclear 
cross polarization was 1.5 s, and total measurement time of a CSI data set was 6 min. 36 s. Cross 
polarization was optimized for the C=C spectral region around 130 ppm.
In vivo studies
Postmortem cross polarization studies on the brain of a neonatal piglet resulted
13in a signal enhancement of 2.2 for the C-1 signals of C-labeled glucose, 
present in the brain (figure 4A and 4B). Figure 4C shows a stack plot of spectra 
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13recorded during infusion of C labeled glucose using heteronuclear cross 
polarization applied in vivo to the brain of a piglet. The time resolution was 3
13minutes. The first spectrum was obtained before the start of the C-1-glucose 
infusion. The subsequent spectra clearly show increasing glucose signals during 
the infusion period and a decrease thereafter.
A
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Figure 4
13C MR spectra of a postmortem neonatal piglet brain containing 13C-1-glucose are shown in figure 
4 A and B. Spectrum A was obtained using heteronuclear cross polarization and spectrum B using 
direct detection and proton decoupling. In vivo 13C MR spectra recorded from a neonatal piglet 
brain before, during and after administration of 13C-1-glucose are shown in figure 4C. Only the C-1- 
glucose spectral region is shown, 80-110 ppm. Experimental parameters: 240 acquisitions, 
repetition time of 750 ms.
13In vivo C MR spectra of the unsaturated triglyceride carbons originating from 
superficial adipose tissue of the human leg are shown in figure 5. For the
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spectrum in figure 5A no decoupling was used whereas for the spectrum in figure 
5B, WALTZ-4 proton decoupling was applied during the signal acquisition period. 
Spectrum C was obtained using both cross polarization and WALTZ-4 
decoupling. Enhancement factors for spectrum B and C are respectively 2.7 and 
10.6 with respect to the non-decoupled spectrum. A gain larger in magnitude 
than 2 for decoupling can be explained by partial NOE. Cross polarization 
accounted for a signal gain of 3.9 in the latter experiment. Until now, no signal 
enhancement could be achieved in vivo for the C-1 signal of glycogen in human 
muscle compared to direct acquisition with enhancement by decoupling and 
NOE.
Discussion
13This study shows that the sensitivity of C MR spectroscopy at the clinical field 
strength of 1.5 T can be improved significantly with the use of heteronuclear 
cross polarization from protons to carbons. The gains obtained for triglyceride
1 13signals are close to the theoretical value, g H / g C » 4. The total gain achieved 
with cross polarization, decoupling and NOE was 10.6 for the unsaturated
13triglyceride carbons in in vivo C MR spectra of the human calf. Polarization 
transfer experiments performed on the human calf with which we compare these 
results are from Bomsdorf et al. (16). They reported a total signal enhancement 
of 6 for the unsaturated fatty acid signals with the use of SINEPT and H 
decoupling at 4 T.
Knüttel et al. (27) demonstrated the detection of unsaturated carbons of fatty
13acids by an indirect method of selecting C attached protons. Theoretically a 
higher signal enhancement is possible with this method but the resulting 
spectrum showed some disadvantages.
Firstly, only one of the lines of the doublet is visible in the proton detected 
spectrum; the other line coincides with the water resonance. Secondly, at the low 
resolution in proton detection, one cannot discriminate between mono- and poly-
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13unsaturated fatty acids, as is possible in the cross polarization enhanced C 
spectrum, see figure 3.
Figure 5.
Natural abundance 13C MR spectra 
of the human calf. Spectra were 
obtained (A) without 1H decoupling, 
(B) with broadband 1H decoupling 
using WALTZ-4 and (C) with 
heteronuclear cross polarization 
optimized for the C=C spectral region 
(130 ppm) and broadband 1H 
decoupling, using the surface coil 
setup. Spectra are plotted on the 
same scaling. Experimental 
parameters: 64 acquisitions, 
repetition time of 3 s, 512 data 
points, and spectral width 8 kHz. 
Subject was a 23 year old female 
weighing 52 kg. The study was 
performed after an informed consent 
was obtained.
A
150 125 100
ppm
In general, indirect detection of carbons in H spectra requires good water 
suppression; it often results in distorted baselines and suffers a low spectral
13resolution (27-29). With labeled compounds often broadband C decoupling is 
required during proton detection to obtain maximum signal gain and resolution.
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1 13This requires much more power than broadband H decoupling during C signal 
acquisition and is of concern regarding RF deposition safety guidelines.
In phantom studies, detection of the C-1 signal of glycogen using heteronuclear 
cross polarization, decoupling and partial NOE resulted in an signal gain of 2.1 
compared to direct detection with decoupling and partial NOE. No signal gain 
was achieved in vivo with respect to H decoupling and partial NOE. A 
significantly lower transfer efficiency for glycogen C-1 compared to lipid signals 
was reported for the SINEPT polarization transfer scheme (16, 17). This is likely 
due to a shorter (effective) T2 of the glycogen C-1 compared to the triglyceride 
carbons. Knüttel et al. showed that detection of liver glycogen is possible using
13proton-detected C spectroscopy (28).
The most promising application of cross polarization in vivo is probably the
13possibility to enhance the time resolution in dynamic C-labeling studies. The 
increase in magnitude of the C-1 signals of glucose in the neonatal piglet brain 
by a factor of 2.2 improves the temporal resolution for detection of these signals
13by a factor over 4. An improved time resolution was also reported in a C 
labeling study of RIF-1 tumors with the use of heteronuclear cross polarization 
(20).
Although the effective chemical shift range of the cross polarization method as 
applied in this study is limited, it is demonstrated that more chemical shift regions 
can be covered by interleaved cross polarization at different frequencies. The 
total measurement time, for cross polarization of two chemical shift regions, can
13still be shorter than the time to obtain a C MR spectrum with the same signal to 
noise ratio, using the pulse-acquire method. Chemical shift selective 
enhancement by cross polarization at two frequencies has also been reported by 
Artemov et al. (20).
In the cross polarization experiments broadband H WALTZ-4 decoupling was 
applied during the acquisition period to enable a comparison with the
1 13conventional H decoupled C MR spectroscopic pulse-acquire technique. 
Because of the chemical shift selective character of the present cross
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polarization method broadband decoupling is not really necessary. The use of 
CW decoupling relaxes RF power deposition and therefore higher duty cycles 
can be used which further decreases measurement times.
Part of the results in this study was obtained with a double surface coil set-up, to 
achieve a high signal to noise ratio. However, one problem arises with surface 
coils and cross polarization techniques: the RF fields of both coils have to match 
to fulfill the Hartmann-Hahn condition. A partly mismatch may have contributed to 
the lack of enhancement for the C-1 signal of glycogen from the muscle as 
compared to an enhancement of 2.1 for this signal of glycogen in solution.
To achieve easy matching of the RF fields over a large volume of interest, we
1 13explored the use of a homogeneous H coil in which a C half volume coil was 
placed. Calibration of the necessary power to be applied to the H coil was 
straightforward. For comparison of the signal gain in the individual CSI voxels the
13RF pulse amplitudes used on the C half volume coil, in the pulse-acquire 
experiment and the cross polarization experiment were set to the same value.
13Signal gain was similar for all voxels in the sensitive area of the C coil, showing 
good Hartmann-Hahn matching of the RF fields over the large volume of the 
phantom.
In this study both non-localized spectra and CSI localized spectra were 
measured. Improvements in localization can be made by using a slice selective 
proton excitation pulse or other means of volume selection like ISIS (8, 9, 18, 19, 
30) which can be placed before the polarization transfer element in the 
sequence.
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Abstract
The purpose of this study was to examine muscle glycogen recovery with 
glucose feeding (GF) in comparison to fructose feeding (FF) during the first eight
13hours after partial glycogen depletion using C Nuclear Magnetic Resonance
13( C-NMR) on a clinical 1.5 T MR system. After measuring the glycogen 
concentration of the vastus lateralis (VL) muscle, glycogen stores of the VL were 
depleted by bicycle exercise in seven male subjects. During eight hours following 
completion of exercise, subjects were orally given either GF or FF, while the
13glycogen content of the VL was monitored by C-NMR spectroscopy every 
second hour. The muscular glycogen concentration was expressed as a 
percentage of the glycogen concentration measured before exercise. The 
glycogen recovery rate during GF (4.2±0.2 %/h) was significantly higher (p < 
0.05) compared to FF (2.2 ± 0.3 %/h). This study shows: 1) muscle glycogen
13levels are perceptible by C-NMR spectroscopy at 1.5 T, 2) the glycogen 
restoration rate is higher following GF compared to FF._______________________
This chapter is based on the publication: Muscle glycogen recovery after exercise during glucose 
and fructose intake monitored by 13C-NMR. A.J. van den Bergh, S. Houtman, A. Heerschap, N.J. 
Rehrer, H.J. van den Boogert, B. Oeseburg, M.T.E. Hopman, J Appl Physiol, 81:1495-1500 (1996)
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Introduction
One of the most important limiting factors in long term muscular performance is 
the depletion of glycogen in the working muscle (1-3). It has been suggested that 
some of the feelings of tiredness associated with overtraining are related to 
lowered glycogen reserves. The resynthesis of muscle glycogen during the 
recovery period is therefore an important metabolic process. Muscle glycogen 
repletion is highly dependent on adequate carbohydrate (CHO) intake (4, 5). 
Biopsy studies of the vastus lateralis (VL) muscle have shown that glucose 
feeding (GF) results in a faster recovery of muscle glycogen levels than fructose 
feeding (FF) (6).
However, the performance of biopsies is difficult at short time intervals from the
13same muscle and it may affect metabolic processes. C Nuclear Magnetic
13Resonance ( C-NMR) spectroscopy has emerged as an appropriate non­
invasive alternative for the assessment of muscle glycogen metabolism. Taylor 
et al. (7) showed that the C-1 resonance from glycogen, which is well resolved 
from other spectral components, can be used to quantify muscle glycogen levels.
13Price et al. (8, 9) studied muscle glycogen resynthesis employing C-NMR 
spectroscopy. After depletion up to 25% of its original amount, glycogen repletion 
was fast in the first hour and slower in the following hours without any feeding.
13Recently Moriarty et al. (10) also used C-NMR spectroscopy to study glycogen 
utilization and restoration in liver and skeletal muscle. In their study, the effect of 
the consumption of glucose and sucrose drinks on glycogen repletion was 
compared. No difference was detected between glycogen recovery rates (GRRs) 
as a result of glucose and sucrose intake. These two studies (9, 10) were 
performed at magnet field strengths of 4.7 and 3.0 T. It has been demonstrated 
that glycogen depletion and recovery can also be observed at the more 
commonly available field strength of 1.5 T (11, 12).
13So far no C-NMR data is available comparing glycogen restoration during GF 
and during FF after glycogen depletion. In the present study muscle glycogen
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recovery was examined the first 8 hours after depletion during GF and FF with
13C-NMR spectroscopy at 1.5 T.
Methods
Subjects. Seven healthy, well trained, male subjects participated in this study 
after an informed consent was obtained. Mean age of the subjects was 24 yr 
(range: 23-27 yr), body mass 78 kg (71-90 kg), height 1.87 m (1.79-1.93 m), and 
fat percentage 10 % (7.0-12.0 %). The Medical Faculty Ethics Committee 
approved this study.
Preparation protocol. At least 1 week before the actual experiments were 
performed, the individual maximum power output (Wmax) was determined on an 
electromagnetically braked bicycle-ergometer (LODE, The Netherlands), using a 
continuous incremental exercise test. The exercise started at 20 Watt (W) and 
increased with 20 W/min. The subjects had to maintain the revolution rate 
between 60-80 revolutions/min (rpm). The individual Wmax was equal to the last 
power output completed for 1 minute with a pedalling rate above 60 rpm.
All subjects performed two glycogen 'depletion-restoration' experiments with at 
least five days in between. Subjects were asked not to participate in exhaustive 
exercise two days in advance of both experiments and to fast (except for water) 
10 hours before the start of the experiments. The actual experiment started with
13the determination of the glycogen content of the VL muscle using C-NMR 
spectroscopy.
Glycogen depletion protocol. All subjects performed bicycle exercise according 
to a protocol described by Kuipers et al. (13), in order to deplete the VL of 
glycogen. Bicycle exercise was performed on an electro-magnetically braked 
bicycle-ergometer. The glycogen depletion protocol consisted of alternating 2 
minute intervals of 90 % Wmax and 50 % Wmax. When the subject was unable 
to perform at 90 % Wmax, the workload was lowered to subsequently 80 %, 70 
% and 60 % Wmax. When 60 % Wmax could not be maintained the exercise
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was stopped and the glycogen content of the VL was determined again by
13C-NMR spectroscopy to measure the extent of the glycogen depletion. The 
exercise was performed at ± 18 °C, and subjects were free to drink water.
-1 0 1 2 3 4 5 6 7 8
Figure 1
Schematic presentation of experiment 1 and 2. During 8 hours following glycogen depletion 
13C-NMR measurements and feeding hours were alternated. The feeding and NMR hours were 
structured as shown in the enlarged sections.
CHO-feeding protocol. During 8 hours after the depletion exercise and the 
second NMR measurement, CHO-ingestion was alternated with glycogen 
measurements every hour, according to figure 1.
During the CHO-feeding hours, subjects drank 500 ml of a CHO solution at 0 
minutes, 250 ml at 30 minutes and 250 ml at 60 minutes. CHO feeding was 
given in counter balanced order: in one experiment GF, in the other experiment 
FF. CHO solutions consisted of 80 g CHO (AMYLUM NV, Belgium) and 1.15 g 
NaCl (MERCK, Germany) dissolved in 950 ml tap-water. The CHO solutions 
were stored at ± 6 °C, for an optimal fast resorption.
Blood- and urine samples were obtained to verify possible loss of glucose. Blood 
glucose was determined in a capillary blood sample from the finger using a 
photometer apparatus (HEMOCUE AB, Sweden). Urine was checked for glucose 
using glucosticks (BAYER, Germany).
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13During CHO intake the actual C-NMR measurement started always exactly 2
13hours after the start of the previous C-NMR measurement.
13C-NMR spectroscopy. VL glycogen levels were monitored by natural
13abundance C-NMR spectroscopy at 1.5 T on a Siemens Magnetom SP63/84 
(SIEMENS, Germany), equipped with a second radio frequency channel. The 
radio frequency probe consisted of two surface coils; a butterfly shaped (0.11 x
1 130.24 m) H-coil and a circular C-coil (0.10 m diameter). The proton coil was 
used for shimming, imaging and decoupling. The line width at half height of the 
water resonance was shimmed below 30 Hz.
13The pulse sequence for acquisition of C-NMR spectra consisted of an adiabatic 
excitation pulse of 2.56 ms length preceded by a low angle hard pulse and a 
dephasing gradient to reduce signals from superficial fat. During the first 65 ms 
of the acquisition period broadband WALTZ-4 proton decoupling was used. A 
chemical shift imaging (CSI) based calibration program was used to compute an 
optimum for repetition time and decoupling power within the guidelines for 
specific absorption rate (SAR) recommended by the FDA (14). Average power 
dissipated at the body surface was 7.5 W/kg and 0.9 W/kg averaged over the 
tissue sampled by the coil, calculated according to Heerschap et al. (12). The 
repetition time was 0.7 s, the sample width 8000 Hz and the number of data
13points was 1024. Each C-NMR measurement consisted of 3000 acquisitions, 
which equals to 35 minutes of acquisition time. The total measurement time was 
50 minutes including imaging and shimming. Possible Nuclear Overhauser 
enhancement (NOE) and saturation of the creatine C-3 resonance under the 
present measurement conditions were determined for 3 volunteers by acquiring 
spectra without decoupling and at a repetition time of 1.4 s. Possible NOE and 
saturation of the glycogen C-1 resonance were determined in a 110 mM (glucose 
units) glycogen solution.
13Positioning. The anterolateral part of the right leg was placed on the C-surface 
coil with the center of the coil at 65 % of the distance from the spina iliaca 
anterior superior to the medial femoral epicondyle. By means of an NMR image
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the position of the VL was checked. Once the first glycogen measurement was 
done at a certain position this position was reproduced as closely as possible for 
the subsequent measurements.
Spectroscopic analysis. The spectroscopic data was analyzed using the software 
package Luise (SIEMENS, Germany). Free induction decays (FIDs) were 
zerofilled to 4 K, multiplied by a 10 Hz gauss filter, Fourier transformed and 
phase and baseline corrected. The C-1 resonance of glycogen and the C-3 
resonance of creatine were fitted to a gaussian line shape. The natural line width 
at one-half maximum of the C-1 resonance of glycogen before exercise ranged 
from 55-89 Hz. The fit program was allowed to vary the line width between 50­
100 Hz in all evaluations. These line width limits for the glycogen C-1 resonance 
were the only prior knowledge constraints used in the fitting procedure. 
Integrated areas of the fits were taken for further evaluation. Signal to noise 
ratios (SNRs) were calculated by the formula: 2.5 x  signal heigt/peaknoise. 
Glycogen restoration data are presented as relative glycogen content (RGC), 
with RGC at time t = (peak integral at t/peak integral before depletion) x  100. 
Statistical analysis. Least-squares linear regression lines were fitted through the 
averaged RGC values (N= 7) of each time point. Slopes and intercepts of both 
monosaccharides were tested by analysis of variance for significant differences. 
All statistical analysis were two-sided, with p-values < 0.05 considered being 
statistically significant.
Results
The mean exercise time of the glycogen depletion protocol was 96 minutes 
(range 54-130 minutes). The mean absolute difference within subjects between 
the first and second glycogen depletion was 7 minutes in duration, which was not 
statistically significant.
Blood glucose during GF (mean ± standard deviation: 6.3 ± 1.4 mM) was 
significantly different (p < 0.05) from blood glucose during FF (4.6 ± 0.6 mM).
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The blood glucose level remained between 3.1 and 10.0 mM throughout both 
feeding periods. Glucosuria was not detected in any subject (loss < 5.5 mM).
chemical shift (ppm)
Figure 2.
13C-NMR spectra recorded pre-exercise (bottom) and post-exercise (top) of the vastus lateralis 
muscle of a volunteer obtained during one experiment with glucose intake. The muscle was 
depleted up to 62 % of the initial glycogen content.
13 13C-NMR spectroscopy. Figure 2 shows two C-NMR spectra obtained at 1.5 T 
from the VL muscle of a volunteer during a depletion-repletion experiment with 
GF. The bottom spectrum was recorded pre-exercise. Glycogen signals can be 
observed at 100.5 ppm (C-1) and also at 70-74 ppm (C-2 - C-5) close to the 
glycerol backbone C-2 resonance. The top spectrum was obtained shortly after 
exercise. Depletion of muscle glycogen is clearly visible in the top spectrum, for 
the resonance at 100.5 ppm and also in the region 70-74 ppm despite the 
overlapping signals from the glycerol backbone. Notice the good reproducibility
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of the spectra for signals of other muscle compounds, for instance creatine at 
157 ppm. The reproducibility, concerning positioning and instrument
13performance, of the C-NMR experiment was examined in 3 volunteers. 
Glycogen signal levels were measured in the non-depleted state under the same 
conditions during two successive examinations. The mean coefficient of variation 
was 5.0 ± 4.0 %. The SNR of the glycogen C-1 resonance in the resting state 
was found to vary between 4 and 13 with an average of 8 ± 1 ( ± SE). A paired t- 
test of the SNR values before GF and FF revealed an effective pairing (one tailed 
P-value: 0.039) and a non-significant difference between these groups ( two 
tailed P-value: 0.99).From each control spectrum, obtained at rest before the 
start of a GF or FF experiment, the glycogen/creatine signal integral ratio was 
determined. This ratio showed, as with the SNR values, a quite large intersubject 
variability: i.e. it ranged from 0.6 to 2.2 with an average of 1.36 ± 0.13 ( ± SE). 
However, for all individuals this ratio was almost the same in both experiments. A 
paired t-test of the data sets revealed a non-significant difference (two-tailed P- 
value: 0.394), the pairing in this test was very effective (one tailed P-value:
0.0019).
Post-exercise
Feeding n Pre-exercise 0 h 2 h 4 h 6 h 8 h
Glucose 7 100 48±4 58±7 64±7 72±5 82±5
Fructose 7 100 43±4 52±7 54±6 56±7 63±5
Table 1.
Mean relative glycogen content pre-exercise and post-exercise. Post-exercise values are mean 
relative glycogen content ±  SE in %; n= no. subjects.
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In order to estimate average muscular glycogen content in the VL from the 
glycogen-to-creatine signal integral ratios, any NOE and saturation of the C-1 
glycogen and C-3 creatine resonances imposed by the present experimental 
conditions (decoupling and scan repetition time) were evaluated. For the C-1 
resonance of glycogen in solution, no NOE and signal saturation were detected; 
this is also expected to be so in vivo (15). For the C-3 resonance of creatine, 
signal saturation was not significant, but an enhancement factor of 1.6 ± 0.17 
(SE) was observed. If we assume the muscular creatine content to be 42.7 mM 
(16) and take a correction factor of 1.6 into account, the average glycogen 
content in the nondepleted state in our volunteers is estimated to be 93 ± 8.8 mM 
(±SE).
time (hours)
Figure 3.
Muscular glycogen levels during fructose (■) and glucose (A) feeding (mean and SEM). Linear 
regression curves are shown with 95 % confidence intervals.
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Glycogen restoration. Table 1 shows the mean RGC values for each point in 
time during GF and FF. During the time course of the CHO intake a linear 
relationship between glycogen content and time was assumed. Figure 3 shows 
the linear regression lines for the glucose (r2 = 0.993) and fructose (r2 = 0.946) 
experiments, lines are drawn with their 95 % confidence intervals.
The intercept, representing the glycogen left after depletion, were 48 ± 1.0 (SE) 
and 45 ± 1.5 % of the initial glycogen content for GF and FF, respectively, which 
is not significantly different. The slope, representing GRR, was significantly 
higher (p < 0.05) during GF (4.2 ± 0.2 %/h) than during FF (2.2 ± 0.3 %/h).
Discussion
Although biopsy studies have shown a faster glycogen restoration rate after 10 or 
more hours with GF compared with FF, only a few studies have focused on GRR 
in humans during the first hours following depletion.
13Taylor et al. (7) demonstrated that in vivo C-NMR measurements of muscular 
glycogen levels can be performed accurately and with a higher precision than in 
biopsy assessment. For the set-up in the present study the precision to measure 
glycogen in the non-depleted state appears to be comparable. Employing 
creatine C-3 signal as an internal reference the estimated average glycogen 
content in the VL of the volunteers is 93 mM, which is similar to the average
13glycogen content measured in the human gastrocnemius by C-NMR employing 
external standardization.
All subjects refrained from exercise 48 hours prior to the experiments and 
performed both experiments at the same time of the day. It is therefore 
reasonable to assume that the initial glycogen content in individuals before 
exercise was the same in both carbohydrate intake experiments and the GRR 
could be compared based on RGC values. This assumption is supported by the 
non-significant difference and the effective pairing between control spectra
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before GF and FF for the glycogen/creatine signal ratios as well as the SNR of 
the C-1 resonance of glycogen.
Because the number of intervals and the total exercise time within subjects was 
about equal in both experiments, it is likely that glycogen was depleted to the 
same level in both experiments. This is confirmed by the intercepts of the 
restoration curves being not significantly different between the two sets of 
experiments.
In this study, the first RGC value measured is high compared to values of 
approximately 20% reported in other studies (2, 6). This can partly be explained 
by the glycogen restoration that occurs during the ± 40 minutes between
13cessation of cycling and the actual C-NMR measurement.
The amount of monosaccharides administered in this study (i.e. 80 g every 2 h) 
should be sufficient to achieve a maximal glycogen resynthesis rate with GF or 
FF (3, 17).
Significant loss of glucose or fructose in the urine or faeces could lead to an 
underestimation of the GRR. If CHO was not absorbed in the bowel, this would 
lead to osmotic diarrhea, which was not observed in this study. Because glucose 
was not detected in the urine of any subject and because fructose in the urine is 
very rare, loss of glucose or fructose may considered to be minimal.
Price et al. (9) found a linear and single-phased relationship between glycogen 
concentration and time after glycogen depletion to 50 %. Therefore, linear 
regression lines were fitted to RGC versus time, to obtain GRR. The finding that 
glucose results in a faster muscle glycogen recovery confirms earlier biopsy 
studies by Blom et al. (6); however, the recovery rates we found were lower: i.e., 
2.2 %/h versus 3.0 %/h for fructose and 4.2 %/h versus 5.8 %/h for glucose. A 
possible explanation for this difference is that glycogen depletion at the start of 
our recovery experiments was less than in the experiments performed by Blom 
et al. At depletion levels down to 20 %, the glycogen recovery has been reported 
to be biphasic (9). A stage of fast recovery followed by a much slower recovery 
rate when a level of 30 mM is reached. Another explanation for the slower
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recovery rate is the 1 hour interval between cessation of exercise and the start of 
the CHO intake. The GRR is reported to be lower if CHO ingestion after exercise 
is delayed (18, 19).
13To our knowledge, there have been no comparable C-NMR studies on 
glycogen restoration with GF or FF with which to compare the results of this 
study. However, it has generally been found in biopsy studies that GRR is higher 
after GF compared to FF (2, 6, 16). Although fructose probably can be 
transformed into glycogen in the skeletal muscle cell (17), several factors may 
contribute to a slower muscle glycogen restoration with FF compared with GF. It 
may be because of a slower absorption of fructose from the intestine. Because 
the blood glucose level during GF is significantly higher than during FF, a higher 
plasma insulin level is expected to be present and thus an increased glucose 
uptake will occur (20). In addition, fructose gives rise to more liver glycogen than 
glucose (4, 21, 22), thus leaving less CHO directly available for muscle glycogen 
resynthesis.
Conclusion. This study demonstrates that GF restores muscle glycogen faster 
than FF during the first 8 hours after depletion to a level of ±40% of the initial
13glycogen content. In general, it appears that C-NMR spectroscopy at 1.5 T is 
suitable to monitor physiological changes in muscle glycogen levels.
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Abstract
Obesity is often accompanied by a decreased ability of insulin to stimulate 
glucose uptake and glycogenesis in skeletal muscle. The aim of this study was to 
investigate the rate of glycogen formation and of muscular glucose content in
relation to insulin sensitivity under euglycemic conditions. We applied a
2 1hyperinsulinemic (430 pmol^m •min ) euglycemic clamp with infusion of 20%
13glucose (30 % enriched with C-1-glucose) to 8 subjects with a wide range of 
insulin sensitivities. Glycogen and glucose levels were monitored simultaneously
13by C MR spectroscopy of the calf muscle on a clinical MR system at 1.5T field 
strength.
Glycogen synthesis rate showed a strong correlation with whole body glucose
13uptake during the clamp (r=0.93, P<0.01). With the use of C MR spectroscopy, 
total muscular glucose content could be determined in vivo, and showed a 
positive, linear correlation with glycogen synthesis rate (r=0.85, P<0.01). 
Preliminary results indicate that the glycogen synthesis rate improves after 
treatment with troglitazone.
This chapter is based on a paper submitted to European Journal of Clinical Investigations
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Introduction
Insulin resistance is a feature of several related disorders like non-insulin 
dependent diabetes mellitus (NIDDM), hypertension, obesity and dyslipidemia (1­
4). In healthy subjects most of the insulin-induced glucose uptake in muscle is 
metabolized to glycogen (5, 6). The principal defect in insulin resistance appears 
to be a decreased insulin-induced glucose uptake in skeletal muscle, which is 
reflected in a decreased glycogen synthesis (6).
The rate of glycogen formation in response to insulin, however is difficult to 
assess in humans in vivo, and requires sequential muscle biopsies. Furthermore, 
the changes in glycogen concentrations maybe so small that they cannot be
13detected with accuracy by current biopsy techniques. In vivo C MR 
spectroscopy of muscle, pioneered by R. Shulman and colleagues (7, 8), offers 
an attractive alternative permitting non-invasive and continuous measurement of
13muscle glycogen levels (9-13). Moreover, with the use of C-enriched glucose 
infusion, the sensitivity of the measurement can be further increased and both 
the monitoring of glycogen synthesis and of total glucose content in muscle has 
become possible (14-17).
13By combining C MR spectroscopy with a hyperglycemic-hyperinsulinemic 
clamp, it was demonstrated that muscle glycogen synthesis rate is decreased in 
subjects with NIDDM as compared to normal subjects (18). Similar findings were
13obtained in obese subjects (19). Up to now, most C MR spectroscopic studies
13 13have used hyperglycemic conditions to measure C-1-glucose and C-1- 
glycogen formation (14, 15, 18). Application of hyperglycemia in nondiabetic 
subjects has some specific disadvantages such as the nonphysiologic glucose 
concentrations, the necessity to use somatostatin to suppress endogenous 
insulin secretion and the high volume load, which all may influence the outcome 
of a study. Only a limited number of studies have been performed on healthy non 
insulin resistant subjects under euglycemic clamp conditions (17, 20, 21), but not 
yet as a function of insulin resistance. In addition, previous measurements were
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performed at high magnetic fields ( > 2T ), not widely available in the clinical 
situation.
The first aim of the present study therefore was to demonstrate that muscle 
glycogen formation and muscle glucose content can be monitored
13simultaneously by in vivo C MR spectroscopy at the commonly available field 
strength of 1.5T, under euglycemic clamp conditions. Secondly, we addressed 
the question how these non-invasively measured parameters correlate with 
insulin sensitivity, in a group of non-diabetic volunteers with a wide range of 
insulin sensitivities.
In addition we tested if the above described measurement conditions could 
detect changes in insulin sensitivity within a subject. In order to perform this 
examination, three insulin resistant obese subjects (BMI > 30) were also studied 
after 8 weeks of treatment with troglitazone. Troglitazone, a member of the class 
of thiazolidine-diones, is capable of improving insulin sensitivity in patients with 
diabetes and in obese subjects (22-26). In vitro studies have shown a beneficial 
effect on glycogen synthesis in human skeletal muscle cultures obtained from 
insulin resistant obese subjects (27). Troglitazone may thus improve glycogen 
synthesis in vivo in humans.
Subjects, materials and methods
Eight healthy male volunteers were studied. Inclusion criteria were: age between 
20-50 years, non-smoking, absence of hypertension and a normal fasting plasma 
glucose concentration. Subjects varied from lean to obese. Three obese subjects 
with BMI > 30 kg/m were studied twice. Subjects received either troglitazone 
400 mg daily, or placebo for a period of eight weeks in a randomized, double­
blind, cross over design. These subjects were selected from a larger randomized 
trial (26). All subjects gave written informed consent. The protocol was approved 
by the hospital ethics committee.
13C MR spectroscopy of the calf muscle, combined with hyperinsulinemic (430
2 1pmol^m •min ) euglycemic clamps were performed after an overnight fast. A
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catheter (Venflon®, 20G , 32m m ) was inserted into a large forearm vein for the
13infusion of insulin and glucose 20%  solution (30 % enriched with C -1- 
glucose)(Cam pro Scientific, Veenendaal, The Netherlands). Blood was sampled  
from the collateral side with 7.5 minute intervals. Plasma glucose levels were  
m easured by the glucose oxidation method (Beckman Glucose Analyzer 2, 
Beckman Instruments Inc, Fullerton, CA, USA). W hole body glucose uptake, 
derived from glucose infusion rate, was calculated during the last hour of the 
clamp and expressed in mmol^kg'^min'1.
Blood samples for insulin m easurem ents were taken before and at the end of the 
euglycemic hyperinsulinemic clamp. Plasma insulin was measured with a double 
antibody radioimmunoassay (interassay coefficient of variation 6 .2% ).
13C M R spectroscopy was performed at 1.5 T  using a whole body M R system  
(Magnetom  SP, Siemens, Erlangen, Germany). Subjects were placed in a supine 
position with the calf muscle positioned on a double surface coil. The coil
13 1configuration consisted of an 11 cm circular C surface coil and a 17 x  23 cm H 
butterfly coil.
The proton coil was used for M R  imaging, magnet field shimming and H 
decoupling. The line width at one-half the height of the w ater resonance was 
shimmed to below 25 Hz.
13Proton decoupled C M R  spectra were collected with a time resolution of 15 
minutes. Data acquisition conditions were as follows: 2 .56 ms sincos excitation 
pulse, pulse repetition time of 180 ms, 1024 datapoints were collected, spectral 
bandwidth of 6 kHz, the number of averages was 5000. Continuous wave proton
1
decoupling was applied at the H frequency of the glycogen C-1 proton during the 
first 50 ms of the acquisition period. Continuous wave decoupling was sufficient 
for decoupling of the glycogen C-1 and glucose C-1 signal regions. The specific 
absorption rate (SAR) at the body surface was kept below FDA guidelines (28) 
using an empirical procedure to predict the local SAR (29).
Spectral analysis was performed using Luise software (Siem ens, Erlangen 
Germ any). Spectra were zerofilled, multiplied by a 10 Hz gaussian filter, phase
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and baseline corrected. Signals of creatine C-3, glycogen C-1 and glucose C-1 a 
and C-1ß were fitted to a gaussian line shape for further analysis.
Basal glycogen concentrations (glycosyl units) were calculated using creatine as 
an internal concentration standard (10, 30-32). Pulse saturation effects and 
nuclear Overhauser enhancement (NOE) were measured for the glycogen and 
creatine signals in separate experiments, from this a total multiplication factor of 
1.17 was derived for the calculation of the basal glycogen concentration. To
13obtain glycogen and glucose concentrations from the in vivo C infusion
13experiments, a correction was made for the C fractional enrichment determined 
from plasma samples obtained at corresponding MR measurement times.
Blood plasma glucose enrichment levels were measured using high resolution 
proton NMR. Preparation of plasma samples prior to NMR consisted of 
deproteinization by centrifugation for 1 hour at 3000 G over a 10 kD filter 
(Sartorius, Göttingen, Germany) (33). From the filtrate 500 ml was taken and 20 
ml of D2O with 2,2,3,3-tetradeuteropropionic acid as internal standard was added. 
Proton spectra were recorded on an AMX-600 spectrometer (Bruker, Karlsruhe, 
Germany). The number of averages was 64, a repetition time of 5 seconds was 
used. Spectra were analyzed using WIN-NMR software (Bruker, Karlsruhe, 
Germany). Fractional enrichment was calculated from the ratios of the Lorentzian
12 13fitted signals of the proton attached to the C / C a-C1-glucose.
Glycogen synthesis rate was obtained by fitting MR data of glycogen increase 
over a period of 75 minutes with linear regression.
13Total muscle glucose levels were determined from the in vivo C MR spectra at 
the end of the infusion when glucose levels were in steady state. Saturation 
effects and NOE are unknown for the glucose C-1 signals with respect to the C-3 
creatine signal so glucose levels are expressed in arbitrary units with respect to 
the creatine signal.
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Figure 1
In vivo 13C MR spectra recorded of the human calf muscle at 1.5T under euglycemic 
hyperinsulinemic conditions. The first spectrum at the bottom shows the natural abundance C-1 
signal of glycogen. During the clamp signals from both glucose anomers are clearly visible. The 
strong increasing intensity for the C-1 signal of glycogen shows the incorporation of labeled glucose. 
The insert show the integral values of the fitted signals from creatine, glycogen and glucose.
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Results
Insulin infusion increased plasma insulin concentrations from 66 ± 12 to 648 ± 47 
pmol/l. Plasma glucose concentrations during the euglycemic (»5mM) clamp 
were stable in all subjects (mean coefficient of variation 5.94%).
Figure 1 shows a stack plot of spectra recorded during an euglycemic
13hyperinsulinemic clamp of C-1-glucose infusion (enrichment 30%), obtained 
from a healthy lean subject; only the region around the C-1 signal of glycogen is
13presented (89-111ppm). The total C MR spectrum shows resonances for 
superficial lipid as well as signals for muscle creatine and other glycogen 
carbons. In the first spectrum the natural abundance glycogen signal is clearly 
visible, the subsequent spectra not only show an increasing signal intensity for 
glycogen but also the appearance of 13C-1 signals for both the a and ß glucose 
anomers. These signals represent the total muscular glucose pool: glucose-6- 
phosphate (G6P), intracellular and extracellular glucose. After approximately 90 
minutes of infusion, the signals representing glucose reach a plateau. The insert 
in figure 1 shows the integral values of the analyzed signals from creatine, 
glycogen and glucose against time. This graph demonstrates that the creatine
13signals were stable during the clamp, indicating a good reproducibility of the C 
MR spectra.
Results of the measurements of the individual subjects are summarized in table
1. The insulin resistant subjects 6, 7 and 8 were measured twice; the suffix -2 
indicates the measurement after troglitazone treatment. As can be derived from 
the table, there was a tendency for a higher basal muscle glycogen content
13measured with in vivo C MR spectroscopy in subjects with a high insulin 
sensitivity expressed as whole body glucose uptake (r = 0.68, p < 0.05). In 
addition, glycogen synthesis rate showed a strong correlation (r = 0.93, p < 0.01) 
with whole body glucose uptake as derived from the clamp (see figure 2). 
Furthermore, a positive linear correlation (r = 0.85, p < 0.01) was found between 
the glycogen synthesis rate and the steady state total muscular glucose content
13measured in vivo by C MR spectroscopy.
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Subject age
(years)
BMI
(kg^m-2)
WBGU
mmol^kg"1^ min"1
[INSULIN]
before
pmol/l
end
pmol/l
[glycogen] 
at t=0 
(mM)
synthesis glucose 
rate content 
(mM/h) (a.u.)
1 28 22 90.4 29 502 77.4 18.6 6.3
2 22 24 76.2 29 402 79.8 11.1 5.5
3 23 21 60.7 43 473 92.7 11.7 4.9
4 47 27 41.9 29 796 76.1 5.3 4.5
5 45 29 43.7 * 652 52.7 6.9 4.3
6-1 28 31 35.2 72 724 64.6 6.8 3.9
6-2 28 31 56.9 79 774 62.9 9.4 5.3
7-1 40 34 29.6 108 731 52.7 4.8 4.1
7-2 40 34 30.7 108 832 45.3 6.5 4.8
8-1 32 33 31.4 * * 51.9 5.2 3.6
8-2 32 33 43.0 100 595 44.1 8.6 4.1
Table 1.
Summarized results from the individual subjects. The suffix -2 indicates the measurement after 
troglitazone treatment of these individuals. Insulin concentrations marked by an * were not 
determined. Insulin concentrations were measured before and at the end of the clamp. Glucose 
content is expressed in arbitrary units.
Discussion
In this study, we demonstrate the feasibility of measuring not only muscular 
glycogen synthesis rate but also total muscular glucose content using
13hyperinsulinemic euglycemic clamp conditions in combination with in vivo C MR 
spectroscopy at the clinical field strength of 1.5 T.
13 13C MR spectroscopy, combined with hyperinsulinemia and C-enriched glucose 
infusion, is uniquely suited for detection of glycogen signals in human tissue like 
muscle and liver, and allows non-invasive and sequential measuring of glycogen 
synthesis rates (7). To date, most studies are performed at high magnetic field
13strengths using hyperglycemic clamp conditions (applying enriched C-1-
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whole body glucose uptake total glucose content
(mmol ■ kg-1 ■ min-1) (a.u.)
Figure 2
Figure 2A shows the correlation between glycogen synthesis and the whole body glucose uptake, 
reflecting insulin sensitivity. Figure 2B shows the glycogen synthesis rate as a function of the total 
muscle glucose content measured by in vivo 13C MR spectroscopy.
13glucose), for optimal sensitivity in in vivo C MR spectroscopy. Only a few report 
on euglycemic clamp conditions in healthy non insulin resistant subjects (17, 20,
21, 34). In this study, we measured muscle glycogen synthesis rates in vivo by
13C MR spectroscopy at 1.5T using hyperinsulinemia in combination with 
euglycemia in insulin sensitive subjects and also in insulin resistant obese 
subjects. The use of normal plasma glucose levels may have advantages, 
especially in the study of insulin sensitivity in nondiabetic subjects.
The tendency of a lower basal muscular glycogen concentration in obese insulin 
resistant subjects is in good agreement with Shulman et al. and Petersen et al. 
(18, 19) who report on a lower basal muscular glycogen concentration in obesity, 
and an even lower concentration in NIDDM.
The range of glycogen synthesis rates measured in this study are comparable to 
the synthesis rates reported earlier during hyperglycemic clamping in normal and 
obese subjects (18, 19). The higher insulin level in our study can explain the
101
Chapter 6
similarity of the glycogen synthesis rates between hyperglycemic and euglycemic 
clamping. Earlier findings (14, 17, 18) that glucose disposal during the clamp is 
mainly accounted for by glycogen synthesis, is reflected in the strong correlation 
between glucose infusion rate and glycogen synthesis rate. Data as presented in 
figure 2a are in good agreement with data obtained by Roussel et al. at different 
glycemic clamp levels (17).
An exciting finding in this study is that the current set-up allows for the non­
invasive determination in muscle of total glucose content simultaneously with the 
content of glycogen. The relation between the steady state muscle glucose 
content and the glycogen synthesis rate appears to be linear. The glucose C-1 
signals arise from extracellular glucose, but intracellular glucose and G6P can 
also contribute. As the C-1 signals of glucose and G6P have similar chemical
13shift positions in the spectra, they can not be discriminated by C MR 
spectroscopy (15). It has repeatedly been reported that under euglycemic 
conditions no accumulation of intracellular glucose occurs (15, 17, 35). Thus a 
reduced total glucose pool as found in insulin resistant subjects can only be 
explained by either a lower intracellular G6P concentration or by a reduced 
extracellular glucose pool compared with insulin sensitive subjects. The 
respective contributions of extracellular glucose and intracellular G6P to the 
glucose signals can be estimated. Assuming 70 ml of extracellular water/kg, and 
using plasma glucose concentrations we can calculate the extracellular glucose 
content during the euglycemic clamp conditions. These conditions were similar 
for the insulin resistant and insulin sensitive subjects in our study (36). Using 
reported values for G6P content obtained during hyperglycemic hyperinsulinemic 
clamp conditions in healthy and insulin resistant obese subjects (19), the 
expected signal change due to G6P can be estimated to be 1.16. The change in 
total glucose content presented here is much larger than can be attributed to a 
change in G6P. A possible explanation is that insulin-mediated muscle specific 
tissue recruitment as suggested by Bonadonna et al. (37), may contribute to an 
increased total muscular glucose content. This is supported by the fact that
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several studies have suggested an important role for insulin-induced 
vasodilatation (38-41).
A decreased glycogen synthesis rate in insulin resistant obese subjects may thus 
be due to a reduced glucose metabolic rate but also due to a defect in glucose
13supply to the cell. Thus the total glucose content measured by in vivo C MR 
spectroscopy reflecting both defects is an important parameter representing 
insulin sensitivity.
Troglitazone, a member of the thiazolidine-diones, a new class of hypoglycemic 
drugs, has been shown to improve insulin sensitivity, in NIDDM as well as in 
obesity (22, 42). Troglitazone presumably improves insulin action at the level of 
the skeletal muscle, but the mechanism of action is complex and only partly 
revealed. In this study we were able to detect changes in glycogen formation in 3 
subjects induced by troglitazone. This action of troglitazone, has only recently 
been reported in muscle cultures (27). Because we studied obese, insulin 
resistant, but nondiabetic subjects, the effect of troglitazone on glycogen 
formation cannot be explained by changes in blood glucose concentration 
(“glucose toxicity”), and probably represents a direct action of the drug on 
skeletal muscle.
13In summary, we demonstrated the feasibility of in vivo C MR spectroscopy at
131.5T in combination with an euglycemic ( C-1 enriched glucose) 
hyperinsulinemic clamp for the measurement of not only glycogen synthesis but 
also total muscular glucose content. Baseline muscle glycogen content tended to 
be lower in insulin resistant subjects, whereas glycogen synthesis rate and total 
muscle glucose content tended to increased in insulin sensitive subjects.
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Summary
In the recent decades, Magnetic Resonance Imaging (MRI) has evolved to a 
routinely used technique to obtain high quality anatomical information. Magnetic 
Resonance Spectroscopy (MRS) does not provide anatomical information but 
chemical information of the tissue studied, in the form of a spectrum. The non 
invasiveness of MRS makes it an attractive alternative for biopsy methods.
13In chapter 1 the current status of human in vivo C MR spectroscopy is 
reviewed. Normal and pathological metabolism that can be studied using natural
13abundance or labeling in in vivo C MR spectroscopy is described. The 
application of double resonance techniques such as decoupling and polarization 
transfer are discussed, with the required coil configurations for such 
experiments. Finally, current localization and quantification methods are 
described.
In chapter 2 and 3 safety issues regarding RF deposition which may lead to 
tissue heating are discussed. In chapter 2, an empirical procedure is described 
to estimate the minimal power required to obtain adequately decoupled spectra. 
This procedure also enables one to calculate the RF energy deposited in the
1 13body during H decoupled C MR spectroscopy. It was shown that for the human 
head, liver, muscle gastrocnemius and muscle vastus lateralis decoupling could 
be performed within RF deposition safety guidelines.
In chapter 3 the thermoregulatory response of the skin was investigated during 
prolonged exposure to several levels of RF radiation by a surface coil. 
Temperature changes induced by RF radiation were measured at the skin of the 
calf muscle by a fluoroptic probe. Although the temperature increase was higher 
at higher applied RF levels, these values did not exceed the recommended 
temperature limit for the extremities. This implies that there is a contradiction 
between the current guidelines for safe MR operation regarding RF specific 
absorption rate and temperature limits for the extremities. The guidelines for 
specific absorption rate may be too conservative for humans with normal 
thermoregulatory function.
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1 13In chapter 4 the potential of heteronuclear { H- C} cross polarization was
13studied for optimization of the signal to noise ratio in in vivo C MR 
spectroscopy. Experiments on the human calf showed a signal gain over tenfold 
by combined application of polarization transfer NOE and decoupling. 
Heteronuclear polarization transfer seems most promising for the study of
13dynamic processes, especially when specific C labeled compounds are
13introduced. A dynamic study of inflow of C-1-glucose in the neonatal piglet 
brain was perfumed.
In chapter 5 the muscle glycogen recovery was examined with glucose feeding in 
comparison to fructose feeding during the first eight hours after partial glycogen
13depletion using C MR spectroscopy. After measuring the glycogen 
concentration of the vastus lateralis (VL) muscle, glycogen stores of the VL were 
depleted by bicycle exercise. During eight hours following completion of exercise, 
subjects were orally given either glucose or fructose, while the glycogen content
13of the VL was monitored by C-NMR spectroscopy. The glycogen recovery rate 
during glucose feeding was significantly higher compared to fructose feeding.
The uptake of glucose in muscle and its metabolism to glycogen in response to
13insulin is reduced in diabetes. To investigate these processes in vivo C MR
13spectroscopy was applied in combination with the infusion of labelled C 
glucose. Furthermore, the effect of troglitazone on insulin sensitivity was 
assessed. The results, as described in chapter 6, showed a correlation between 
the glycogen synthesis rate and the whole body glucose uptake. With the use of
13C MR spectroscopy, in vivo muscular glucose levels could be detected, and 
showed a positive, linear correlation with glycogen synthesis rate. The improved 
glycogen synthesis rate after treatment with Troglitazone is a good indication for 
a positive effect of this drug on insulin resistance.
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Magnetische Resonantie Imaging (MRI) wordt tegenwoordig routinematig 
toegepast voor het verkrijgen van anatomische afbeeldingen. Magnetische 
Resonantie Spectroscopie (MRS) levert een spectrum op in plaats van een 
anatomische afbeelding. Het spectrum bevat informatie over de chemische 
samenstelling van het onderzochte weefsel. Daar MRS een noninvasieve 
techniek is, is het een aantrekkelijk alternatief voor invasieve biopsiemethoden.
13In hoofdstuk 1 worden de huidige ontwikkelingen in in vivo C-MRS gericht op 
humane fysiologie en pathologie beschreven. De toepassing en voordelen van 
dubbelresonantie technieken zoals protonontkoppeling en polarisatietransfer 
worden beschreven samen met de daarvoor benodigde speciale Radio 
Frequente (RF) spoelontwerpen. Tenslotte wordt er een overzicht gegeven van 
lokalisatietechnieken en quantificatiemethoden.
In de hoofdstukken 2 en 3 wordt er aandacht besteed aan de veiligheid van 
MRS. Met name de absorptie van RF-energie, die kan leiden tot lokale 
opwarming van het weefsel, komt hier aan de orde. In hoofdstuk 2 wordt een 
methode beschreven, die het mogelijk maakt de minimaal benodigde energie te 
bepalen waarbij adequaat ontkoppelde spectra kunnen worden verkregen. Deze 
methode kan bovendien gebruikt worden om te bepalen aan welke hoeveelheid 
RF-straling het lichaam wordt blootgesteld. Met behulp van deze methode is
13aangetoond, dat protonontkoppeling tijdens C-MR spectroscopie van het hoofd, 
lever of beenspieren toegepast kan worden binnen veiligheidsrichtlijnen.
In hoofdstuk 3 wordt de temperatuurstijging van de huid onderzocht als gevolg 
van langdurige blootstelling aan verschillende niveaus van RF-straling. Ofschoon 
er een relatie is tussen het RF-stralingsniveau en de bereikte temperatuur wordt 
bij vermogens boven de richtlijnen de temperatuurlimiet, opgesteld voor de 
extremiteiten, niet overschreden. De resultaten suggereren dat er een 
tegenstrijdigheid is tussen de temperatuur- en vermogenslimieten voor de 
extremiteiten.
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1 13De mogelijkheden van heteronucleaire ( H- C) polarisatie transfer technieken 
ter verbetering van de gevoeligheid worden onderzocht in hoofdstuk 4. Meer dan 
een tienvoudige verbetering was haalbaar voor onderhuids vetweefsel door 
toepassing van zowel polarisatietransfer, “NOE” en protonontkoppeling. Deze 
techniek is het meest waardevol voor de bestudering van dynamische processen
13met specifiek C gelabelde verbindingen zoals glucose. De toepasbaarheid 
hiervan is succesvol getoetst op de hersenen van een biggetje.
13In hoofdstuk 5 wordt met behulp van in vivo C MRS het herstel van 
spierglycogeen onderzocht tijdens voeding met glucose in vergelijking tot 
voeding met fructose. Na het meten van de basale spierglycogeenconcentraties
13met C MRS, werd de spier uitgeput door uitvoering van een fietsprotocol.
13Gedurende de eerste 8 uur in de herstelfase werden C MRS metingen 
afgewisseld met suikeropname (glucose of fructose). Glucosevoeding 
resulteerde in een significant sneller spierglycogeenherstel dan fructosevoeding. 
De opname in de spier van glucose en de omzetting daarvan in glycogeen onder 
invloed van insuline spelen een belangrijke rol in de pathologie van diabetes. Om
13deze processen te kunnen meten werd C MRS toegepast in combinatie met
13infusie van specifiek gelabeld C-1-glucose. Daarnaast werd het effect van het 
medicijn Troglitazone op insulineresistentie onderzocht. De resultaten van dit 
onderzoek zoals beschreven in hoofdstuk 6, lieten een correlatie zien tussen de 
insulinegevoeligheid en de glycogeensynthese-snelheid. Daarnaast was er ook 
een positieve lineaire correlatie tussen het totale spierglucosegehalte en de 
glycogeensynthese. De verhoging van de glycogeensynthese als gevolg van 
behandeling met het middel Troglitazone in insuline resistente personen is een 
goede indicatie voor de positieve werking van het medicijn.
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De totstandkoming van dit proefschrift was geen sinecure voor de betrokken 
promovendus. Zonder de invloed en betrokkenheid van vele mensen zou dit 
resultaat niet voor u liggen. Het is mij dan ook een groot genoegen om iedereen 
die heeft bijgedragen te kunnen bedanken. Een aantal van hen zal ik noemen, in 
de hoop niemand te kort te doen.
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Brocades te Delft (dr. ir. O. Misset) en Organon International b.v. te Oss (dr. 
C.W. Funke) onderzoek wat zich richtte op de stabiliteit en activiteit van 
biologische vlekoplossers (proteasen) en op de toepassingen van fourier 
transform infrarood spectroscopie. In een afstudeeropdracht bij de 
laatstgenoemde organisatie deed hij onder leiding van dr. J-R. Mellema structuur 
analyse onderzoek naar enkele oligopeptiden met behulp van geavanceerde 2D 
NMR-spectroscopie.
In aansluiting op de vervulling van de dienstplicht in 1989 te Roosendaal als 
hospik, vervolgde hij zijn opleiding in de vorm van een doctoraalstudie aan de 
Katholieke Universiteit Nijmegen. In de studierichting Scheikunde koos hij als 
hoofdvak Farmaco-Chemie. Onder begeleiding van prof. dr. C.A.M. van 
Ginneken ü-, dr. F.G.M. Russel, dr. R. de Miranda, dr. P. Cox en mevrouw dr. S. 
Boom werd onderzoek verricht naar organisch aniontransport in proximale tubu- 
luscellen uit de rattenier. In januari 1992 werd het doctoraal examen afgelegd. 
Vanaf februari 1992 tot februari 1997 was hij als assistent in opleiding werkzaam 
bij de afdeling Radiologie van het Academisch Ziekenhuis Nijmegen St. 
Radboud. Het tijdens deze periode uitgevoerde onderzoek, begeleid door prof. 
dr. A. Heerschap, staat beschreven in dit proefschrift.
De heer A.J. van den Bergh heeft in 1994 een stipendium ontvangen voor een 
korte wetenschappelijk stage aan de Johns Hopkins Medical School, Department 
of Radiology, in Baltimore USA. Aldaar werden diverse dubbel resonantie 
technieken en protocollen voor de humane toediening van 13C gelabeled 
materiaal bestudeerd.
In de periode na het AIO-schap tot oktober 1998 was A.J. van den Bergh als 
onderzoeker werkzaam aan een onderzoek gesubsidieerd door Glaxo 
Wellcome. Dit project is totstandgekomen in samenwerking met de vakgroep 
Farmacologie (prof. dr. P. Smits), de afdeling Interne Geneeskunde (dr. C.J.J. 
Tack en drs. G. Vervoort) en de afdeling Radiologie (prof. dr. A. Heerschap) van 
het Academisch Ziekenhuis Nijmegen St. Radboud.
Thans is A.J. van den Bergh als onderzoeker betrokken bij een project met als 
doel het meten van foetale hersenen met behulp van 1H MR spectroscopie.
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